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Abstract 
 
The equine hoof lamellar tissue is a highly specialized structure that plays a critical 
role in the suspensory apparatus of the distal phalanx (SADP). Failure of this normal 
attachment between distal phalanx and hoof is a major consequence of laminitis. Several 
conditions have been associated with laminitis in the past, but those related to insulin 
resistance (IR) or excess of glucocorticoids appear to be involved in the majority of the 
reported cases. The common factor in these conditions is hyperinsulinemia. Besides the main 
role of insulin in regulating glucose metabolism, it is involved in diverse physiologic process 
such as vascular modulation and cellular growth and proliferation. The role of insulin in 
laminitis has been assessed by different authors and new experimental model has arisen 
recently to induce laminitis after systemic administration of high concentrations of the 
hormone. However, the exact mechanism involved in the pathophysiology of the disease 
remains unclear.  
Utilizing the minimally invasive technique of tissue microdialysis, this work aimed to 
evaluate the local effects of insulin, delivered in higher than normal concentrations into the 
lamellar interstitial fluid, by assessing the suggested potential mechanisms involved in this 
form of the disease: vasodilation, derangements of energy metabolism, and epidermal cellular 
proliferation. The latter was assessed using 5-ethynyl-2’-deoxyuridine (EdU), a novel marker 
of mitotic activity. 
Insulin was delivered locally to the forefeet of healthy, Standardbred horses using one 
of the limbs as treatment (n=6) and the contralateral as control (n=6). Although they did not 
reach significance, changes in lamellar glucose metabolism (decreased interstitial glucose) 
were observed after delivering an approximated amount of 0.5 µg/ml for 24h at 1 µL/min via 
microdialysis to the sublamellar tissue. No variations were detected in the other measured 
metabolites (lactate, pyruvate and urea). The local delivery of insulin did not affect the 
microcirculation of the lamellae (no changes in urea clearance). These results support the 
hypothesis of insulin modifying lamellar cellular metabolism by increasing glucose uptake 
and consumption. This metabolic shift may be relevant in terms of modifying the stability of 
the cytoskeleton of the epidermal basal cells (EBCs) and the organization of lamellar tissue. 
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To determine if high concentrations of insulin delivered locally affected the 
proliferation rate of the EBCs, a second experiment was performed in eight healthy, 
Standardbred horses. The microdialysis protocol was completed as for the six initial horses. 
After insulin was delivered for 24h, the proliferation marker EdU (5-ethynil-2’-deoxyuridine) 
was administered to both forefeet (control and treatment). The EdU technique was developed 
and standardized as part of this project for the study of the lamellar proliferation. 
Significative changes in the proliferation rate or total number of cells were found after 24h of 
local delivery of high concentrations of insulin to the lamellar tissue. These changes were 
restricted to the tissue sections harvested from close to the microdialysis membrane (L1) of 
the treatment group. A histomorphometric analysis was added to the experimental protocol to 
examine changes in the organization of the lamellae. The primary epidermal lamellae (PELs) 
and the non-keratinized tip of the PELs (NKPELL) measured significantly longer in the 
tissue sections of the treatment group containing the microdialysis probe. No changes were 
detected in the length of the secondary epidermal lamellae (SELs) or the keratinized axis of 
the PELs (KPELL). These results suggest a possible direct effect of insulin on lamellar tissue 
organization, which could be responsible for weakening of the SADP as was hypothesized by 
previous authors. 
This project has contributed to the understanding of the mechanism involved in the 
pathophysiology of insulin-induced laminitis. Despite the results being not completely 
conclusive, this work is the first to assess the direct local effect of insulin in the lamellar 
tissue and provides new questions and directions for future research. Further work should be 
focused on the study of the concentration and transport of insulin in the lamellar tissue as 
well as the interactions between insulin and its receptors in the lamellae. The study of the 
relationship between hyperinsulinemia, the cytoskeleton of EBCs and the failure of the SADP 
will contribute to the understanding of the insulin-induced laminitis model.  
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Chapter 1: Introduction, literature review and project aims 
 
 
1.1 Introduction 
The equine hoof lamellar tissue is a highly specialized structure that plays a critical role in the 
suspensory apparatus of the distal phalanx (SADP) (Pollitt, 2010). The failure of this normal 
attachment between distal phalanx and hoof is a major consequence of laminitis. Several 
conditions have been associated with laminitis in the past  (Heymering, 2010), but those 
related to insulin resistance (IR) or excess of glucocorticoids appear to be involved in the 
majority of the reported cases. The common factor in these conditions seems to be 
hyperinsulinemia (Johnson et al., 2004; McGowan, 2010; Treiber et al., 2006a; Treiber et al., 
2006b). Besides the main role of insulin in regulating glucose metabolism, it is involved in 
diverse physiologic process such as vascular modulation and cellular growth and 
proliferation. The role of insulin in laminitis has been assessed by different authors (Asplin et 
al., 2010; Bailey and Harris, 2006; Bailey et al., 2007; de Laat et al., 2011a; du Toit and 
Trawford, 2010; Jones et al., 1998; Kronfeld, 2005; McGowan, 2008; Walsh et al., 2009) and 
a new experimental model has arisen recently to induce laminitis after the administration of 
high concentrations of the hormone (Asplin et al., 2007; de Laat et al., 2010a). However the 
exact mechanism involved in the pathophysiology of the disease remains unclear. The aim of 
this work is to evaluate the local effects of insulin delivered in higher than normal 
concentrations into the lamellar interstitial fluid, assessing the suggested potential 
mechanisms involved in this form of the disease: vasodilation, derangements of energy 
metabolism, and epidermal cellular proliferation. This section provides a brief review of the 
endocrinological aspects of laminitis, including the role of insulin and suggested pathways to 
disease. 
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1.2   Literature Review 
 
1.2.1 Structure of the inner hoof wall 
The equine hoof is a hard keratinized structure covering the distal end of the digit. In 
addition to protecting the inner structures of the hoof, it dampens and transmits the impact 
forces during standing or locomotion of the horse (Goodman and Bonney, 2007). It is 
constituted by three layers: the stratum externum, stratum medium and stratum internum 
(Stump, 1967).  
The stratum externum is a protective tough layer to inhibit dehydration (Stump, 
1967). The stratum medium is the thickest of the three layers and is characterized by its 
tubular and intertubular horn structure. It is the result of the proliferative activity of the 
epidermal basal cells (EBCs) lining the basement membrane of the coronal corium. 
Numerous papillae project from the coronet corium and fit into the holes of the epidermal 
coronary groove, nourishing the EBCs which proliferate and differentiate into keratinocytes. 
These keratinocytes mature forming a keratinized cellular matrix in which the hoof wall 
tubules are embedded. The hoof wall is apparently reinforced by the tubules but it is the 
intertubular material that provides mechanical strength and stiffness (Bertram and Gosline, 
1986; Kasapi and Gosline, 1998) . The cross-sectional shape of the tubules changes from 
elliptical in the outer region to circumferential in the inner region; in addition the number of 
tubules is higher in the outer zones of the stratum medium and declines as it gets close to the 
stratum internum. This special  conformation of the stratum medium confers the resistance 
and elastic properties to the hoof wall (Kasapi and Gosline, 1998) 
The stratum internum is constituted by the epidermal lamellae and the lamellar 
corium; together they play a fundamental role linking the dorsal surface of the distal phalanx 
to the stratum medium of the hoof wall. The connection between hoof and bone is termed the 
suspensory apparatus of the distal phalanx (SADP) (Pollitt, 2010) which includes the dermal 
and epidermal lamellae, and the connective tissue of the coffin bone (Budras, 2009). The 
epidermal lamellae are constituted by approximately 600 primary epidermal lamellae (PELs) 
disposed parallel to each other from the deep edge of the coronary groove to the junction with 
the sole (Stump, 1967). Along the length of each PEL, 150 to 200 secondary epidermal 
lamellae (SELs) are found increasing the contact surface between the epidermal and dermal 
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layers. This particular disposition of the epidermal lamellae is an important specialization of 
the lamellar tissue to accomplish its suspensory function (Pollitt, 2010). 
The corium or dermis, consists of a highly vascularized and innervated dense matrix 
of connective tissue underlying the hoof wall (Pollitt, 1998). It is comprised by the coronet 
corium, the lamellar corium and the sole corium. The sole corium, as well as the previously 
describe coronet corium, has papillae that fit into a socket in the epidermal sole. In contrast, 
the lamellar corium is interlocked with the epidermal lamellae forming the primary (PDLs) 
and secondary dermal lamellae (SDLs). The vasculature of the corium is provided mainly by 
branches from the coronary circumflex artery and the terminal arch; in turn both arteries are 
branches of the medial and lateral digital arteries (Pollitt, 2010). The lamellar dermal 
vasculature consists of blood vessel sheets arranged perpendicularly to the hoof wall 
exhibiting numerous arterioles, capillaries and extensive venous plexus (Marais, 1989; Nasu 
et al., 1998). The vessels of the dermal papillae of the coronary, sole and frog regions share 
the same structural organization; a central artery and vein spiralled around each other, 
surrounded by a sheath of fine capillaries (Pollitt and Molyneux, 1990). The venous 
circulation is drained from the foot through three different plexuses: the dorsal venous plexus, 
the palmar/plantar venous plexus and the coronary plexus. The three plexuses are drained by 
the medial and lateral digital veins (Pollitt, 2010). Arteriovenous anastomoses (AVAs) have 
been described in both the dermal papillae and the dermal lamellar vasculature in an 
estimated density of 500 per cm2 (Pollitt and Molyneux, 1990). They are conformed by 
specialized cells metabolically more active than other endothelial cells of contiguous vessels 
and play an important role in tissue metabolism, thermoregulation and pressure modulation 
(Molyneux et al., 1994). 
The dense matrix of connective tissue of the corium is responsible for connecting the 
dorsal surface of the distal phalanx to the basement membrane (BM) at the dermal-epidermal 
junction. The BM comprises a multiprotein complex that aids the attachment of epidermal 
keratinocytes to the underlying dermis (McMillan et al., 2003). It is a key structure of the 
SADP, connecting bands of collagen I from the dorsal surface of the distal phalanx with the 
EBCs of the SELs (Pollitt, 2010). The BM is constituted by an axial skeleton of collagen IV 
and several glycoproteins, both together form the electron dense layer termed lamina densa 
(McMillan et al., 2003). At its epidermal side, the BM binds the plasmalemma of EBCs 
through electron dense adhesion plaques or hemidesmosomes (HD) (Pollitt, 2010). The 
proteins of the hemidesmosomes plectin and BP230 (intracellular plaque proteins) connect 
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the keratin cytoskeleton of the EBCs to the transmembrane integrin α6β4 and BP180. These 
two proteins have domains at both sides of the plasmalemma and bridge the 
hemidesmosomes to the lamina densa through the anchoring filaments composed by 
Laminin-332 (formerly laminin-5)(Jones et al., 1998). At the dermal side of the BM, long 
collagen VII filaments bind the lamina densa to the connective tissue (collagen I) of the 
parietal surface of the distal phalanx (Pollitt, 2010).  
 
1.2.2 Laminitis: clinical and histological findings 
Laminitis has been defined as the failure of the distal phalanx to maintain its 
attachment to the lamellae of the inner hoof wall (Pollitt, 2004). The progression of the 
disease has been divided in three phases: the developmental phase, the acute phase and the 
chronic phase. The developmental phase extends from the exposure of the horse to the 
inciting cause to the appearance of foot pain. It is in this phase when the destruction of the 
SADP begins, damaging progressively the inner structures of the hoof capsule. The onset of 
foot pain and lameness at the trot give rise to the acute phase, which last up to the time when 
radiological evidence of rotation of the distal phalanx is present. This event indicates the start 
of the chronic phase, which can last indefinitely (Pollitt, 2004). The disease severity can vary 
along the different phases from mild or subclinical manifestation that may go unnoticed to 
severe manifestation as persistent, mild lameness, continued severe foot pain, further 
degeneration of lamellar attachments, recumbency, hoof wall deformation and loss of 
function, leading in many cases to euthanasia (Hunt, 1993). 
The different grades of severity described below, correspond to the clinical 
classification described by Obel (1948) which has been universally adopted. 
Obel Grade I: At rest the horse will alternately and incessantly lift the feet, lameness is not 
evident at the walk, but a short stilted gait is noted at the trot.  
 
Obel Grade II: The horse moves willingly at the walk, but the gait is characteristic of 
laminitis. A hoof can be lifted off the ground without difficulty.  
 
Obel Grade III: The horse moves very reluctantly and vigorously resists attempts to a 
forefoot.  
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Obel Grade IV: The horse must be forced to move and may be recumbent. 
During the different stages of laminitis several changes occur to the lamellar tissue. 
The histological alterations occurring in acute laminitis cases are correlated to the clinical 
progression of the disease and have been classified with light microscopy by (Pollitt, 1996) 
into three grades: 
Grade 1: SELs are decreased in width, elongated and their tips are more pointed than normal. 
The nuclei shapes are round instead of oval and abnormally orientated with their long axes 
parallel to the long axis of the SEL. The BM separates from the EBCs, being more noticeable 
at the SELs’ tips where a cytoplasm-free space resembling a teat-shaped bubble is formed 
(Pollitt, 1996).  
Grade 2: SELs are further elongated and separated from the basal cells. PEL tips are 
stretched and undulated, however basal cells at the tips of PELs are the least abnormal. 
Mitotic figures may be found as a suggested proliferative response. The change of shape of 
the EBCs at the SELs nuclei is more evident at this grade, being found closer to the BM 
rather than their normal apical position. SDL shows a lack of connective tissue and between 
the bases of the SELs the BM was absent. The major difference with the previous grade is the 
further separation of the BM from the edge of the PEL axis (Pollitt, 1996).  
Grade 3: The normal arrangement of the lamellar anatomy has been lost completely. The 
PEL tips are tapered and shrunken. SELs are extremely elongated and stretched with no 
recognisable connective tissue in between of them. Most of the epidermis appeared as an 
amorphous mass of elongated nuclei and basal cell cytoplasm scattered with the remnants of 
the keratinised axes of SELs. Some of the epidermal cell nuclei are pyknotic, spindle shaped 
and elongated in the direction of the lamellae. The PELs tips consist entirely of collapsed 
tubes of BM lacking of epidermal cells. PAS-positive neutrophils can be found surrounding 
the PEL tips and within the epidermal compartment between layers of BM (Pollitt, 1996). 
The histological classification described by Pollitt using light microscopy, was based 
on laminitic horses induced utilizing the alimentary carbohydrate overload (ACO) protocol, 
firstly described by Garner et al. (1975).  These lesions have been observed in the different 
experimental laminitis models with slightly variations. BM damage is more extensive and 
severe in horses treated with oligofructose (OF) than those treated with insulin. Additionally, 
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BM derangement has been described as more extensive in horses than ponies subjected to 
hyperinsulinemia (de Laat et al., 2011b), where only small and occasional areas of BM 
separated from the tips of SELs were identified (Nourian et al., 2009). The difference of 
bodyweight between horses and ponies (and therefore the different forces of mechanical 
distraction acting on the lamellar tissue) has been suggested as a possible explanation for this 
variability (de Laat et al., 2011b).  
The presence of a high number of mitotic figures and apoptotic cells is a characteristic 
finding in the lamellae of ponies (Asplin et al., 2007; Nourian et al., 2009) and horses (de 
Laat et al., 2010b) subjected to experimental hyperinsulinemia. Mitotic figures have been 
also described in other forms of laminitis (Faleiros et al., 2004; Galey et al., 1991; Pollitt, 
1996) and associated with reparative processes.  
Abnormal proliferative changes have been also described in the lamellar tissue of 
Kaimanawa feral horses of New Zealand diagnosed with chronic laminitis. The main 
histopathological lesions found were the presence of excessive cap horn production and 
abnormal tips of PELs (multi-branched, attenuated and dystrophic). Presumably this chronic 
presentation of the disease might be associated to consumption of high palatable pastures or 
IR (Hampson et al., 2012). 
 
1.2.3 Laminitis pathophysiology 
The pathophysiology of laminitis has been studied for several years and many 
hypotheses have been proposed during the last decades trying to elucidate the pathway that 
leads to lamellar failure. In the last 30 years more than 80 conditions have been associated 
with laminitis (Heymering, 2010), however most of them are based on observations and only 
a few conditions have been replicated through experimental models (Asplin et al., 2007; de 
Laat et al., 2010a; Galey et al., 1991; Garner et al., 1975; van Eps and Pollitt, 2006), with an 
incomplete understanding of the pathologic process (Heymering, 2010). Due to the diversity 
of causes for laminitis the idea of a single pathway explaining the disease seems to be very 
unlikely. Thus the different natural presentations of laminitis have been grouped into three 
categories: sepsis related laminitis, supporting limb laminitis and endocrinopathic laminitis 
(Katz and Bailey, 2012). 
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 Sepsis related laminitis is by far the most studied form of the disease.  Gastrointestinal 
injury from various insults, pleuropneumonia and septic metritis are some of the conditions 
usually related to sepsis and laminitis (Belknap and Black, 2012). In this form of the disease, 
vascular delivery of “triggering factors” from diverse origins appears to be responsible for 
activation of enzymatic and/or metabolic events in the lamellar tissue leading to the dermo-
epidermal disruption (Pollit 1999). Although the exactly mechanism through which sepsis 
leads to laminitis remains unclear, the main instigating events appear to be: activation of 
matrix metalloproteinases (MMP) 2 and 9, increased ADAMTS activity, lamellar leucocyte 
infiltration and vascular changes (Coyne et al., 2009; Faleiros et al., 2011; Loftus et al., 2009; 
Mungall and Pollitt, 1999; Roach et al., 2002).  
 Supporting limb laminitis (SLL) occurs in the healthy limb of horses with severe 
unilateral lameness when it persists. SLL incidence has been estimated between 11%- 16% of 
horses at risk (Virgin et al., 2011). Cyclic loading of the horse feet seems to plays an 
important role in the normal equine foot to avoid ischemia. Reduction of this cycling activity 
is thought to decrease the lamellar blood flow and may be involved in the pathophysiology of 
the disease. Ischemia and insufficient glucose delivery to the lamellae appear to be the main 
factors leading to the SADP failure in SLL (van Eps et al., 2010). 
This literature review is focused on the endocrinopathic aspects of laminitis. For 
detailed discussion about sepsis related laminitis and SLL, the reader is directed elsewhere 
(Belknap and Black, 2012; Orsini, 2012; van Eps et al., 2010). 
 
1.2.3.1 Endocrinopathic laminitis 
Endocrinopathic laminitis arises from hormonal rather than inflammatory conditions 
(Katz and Bailey, 2012) and has been mainly associated with pathologies involving excess of 
glucocorticoids (endogenous or exogenous) and/or insulin resistance (IR) (McGowan, 2010). 
In epidemiological studies from Australia and Finland >80% of horses with a history of 
laminitis had evidence of an endocrinopathy (McGowan, 2009). Grazing lush pasture, also 
thought to result in laminitis via insulin imbalances, was the most prevalent form of laminitis 
in the USA, accounting for approximately 50% of all diagnosed cases (Kane et al., 2000). 
Similar percentages have been described in the United Kingdom with 61% of laminitis cases 
occurring in animals kept at pasture (Hinckley and Henderson, 1996).  
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The pathophysiology of pasture-associated laminitis is still unclear but the most 
accepted explanation is based on the carbohydrate overload model (Bailey et al., 2004; Eades, 
2010). During periods of high risk, mainly spring and early summer or after heavy rains, the 
grass grows faster and accumulates considerable amounts of non-structural carbohydrates 
(fructans, simple sugar or starches). The ingestions of this forage generates changes in the 
hindgut microbiome and damages the intestinal epithelial cells favouring the absorption of 
laminitis triggering factors into circulation. These events have been replicated by the 
oligofructose (OF) and the alimentary carbohydrate overdose (ACO) experimental models of 
laminitis, first described by (Garner et al., 1975) and (van Eps and Pollitt, 2006), respectively. 
In those experimental models, sepsis is considered as the factor triggering the disease through 
different mechanisms not yet fully understood (Belknap and Black, 2012). The role of sepsis 
and endotoxemia in the pathogenesis of pasture-associated laminitis has not been determined 
(Geor, 2010). Furthermore, only a small proportion of any population develops pasture 
laminitis during periods of high risk suggesting that consumption of lush pastures during 
these periods could trigger the expression of an underlying genetic predisposition to laminitis 
(Bailey et al., 2004). Horses with an insulin-resistant phenotype are prone to the development 
of pasture-associated laminitis (Frank et al., 2006; Geor and Frank, 2009; Treiber et al., 
2006b). A study conducted in ponies showed that intake of feeds rich in carbohydrate 
constitutes a risk factor to laminitis and may exacerbate hyperinsulinemia in predisposed 
animals. The term prelaminitic metabolic syndrome (PLMS) was used to describe the 
phenotype of these predisposed animals, including among the risk factors: body condition, 
plasma triglyceride concentration, insulin sensitivity and insulin secretory response (Treiber 
et al., 2006b). These characteristics were included in the ACVIM Consensus Statement 
(Frank et al., 2010) and now this condition is known as Equine Metabolic Syndrome (EMS).  
EMS is characterized by the presence of obesity or increased adiposity in specific 
locations, usually subcutaneous adipose tissues surrounding the nuchal ligament in the neck, 
fat pads close to the tail or fat accumulated behind the shoulders, prepuce or mammary gland 
region. Insulin resistance (IR) (and hyperinsulinemia) is another characteristic of EMS and is 
accompanied by obesity in the majority of cases; although affected horses can have an 
apparently normal body condition. Obesity might be involved as a cause/consequence of IR 
through down-regulation of insulin pathways induced by adipokines and cytokines produced 
in adipose tissue of horses with EMS (Frank et al., 2010). The predisposition to laminitis is 
the third component of the phenotype for the majority of equids affected by EMS. Other 
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alterations such as hypertriglyceridemia, hyperleptinemia, arterial hypertension, reproductive 
alterations and increased systemic markers of inflammation may also be present (Frank et al., 
2010). 
Pituitary Pars Intermedia Dysfunction (PPID), also known as equine Cushing’s 
syndrome (ECS), is the term used to describe a collection of clinical signs attributed to the 
loss of dopaminergic inhibition of the pars intermedia of the pituitary (Schott, 2002). As well 
as other neurodegenerative diseases, the most important risk factor for the development of 
PPID is age, affeceting 15 to 30% of aged horses (Brosnahan and Paradis, 2003). Clinical 
signs of PPID include: hirsutism, muscle atrophy, polyuria/polydipsia, hyperhidrosis, 
abnormal fat distribution and insulin resistance, immunosuppression, behavioural 
abnormalities, infertility, neurologic and laminitis (McFarlane, 2011). More than 50% of 
horses affected by PPID suffer chronic insidious-onset laminitis, which has been described as 
the major clinical complication of the disease (Schott, 2002). 
PPID and EMS are both metabolic conditions that predispose horses and ponies to 
laminitis and may even induce the condition (Tadros and Frank, 2011). The association 
between laminitis and EMS or PPID has been widely described and the common factor 
between these conditions seems to be IR and subsequent hyperinsulinemia (Johnson et al., 
2004; McGowan, 2010; Treiber et al., 2006a; Treiber et al., 2006b). Horses with PPID 
usually have IR as a consequence of the inhibiting effect of glucocorticoids on insulin 
activity, causing hyperinsulinemia (Johnson et al., 2004). This has been detected in a 
considerable proportion of PPID affected horses (McGowan et al., 2004) and consistently 
associated with laminitis in these cases (Walsh et al., 2009).  In addition, in a field study, 
horses with EMS and PPID presented with significantly higher plasma insulin concentrations 
than control horses, suggesting the baseline plasma insulin concentrations as a potential 
indicator of susceptibility of horses to laminitis (Walsh et al., 2009).  
 
IR is a general term for the inability of a normal concentration of insulin to produce a 
normal response in the target tissues (Kahn, 1978). It was suggested by (Asplin, 2009) as a 
possible cause of laminitis due to an impaired glucose uptake by the lamellar tissue. This 
hypothesis was based on the high metabolic requirements of the lamellar tissue, even higher 
that of the head (Wattle and Pollitt, 2010) and the need of the lamellae to consume glucose to 
maintain hemidesmosome integrity between the BM and the EBCs of the lamellae (French 
and Pollitt, 2004). Later studies characterizing the glucose uptake in the lamellar tissue 
11 
 
showed a strong reaction for glucose transport protein GLUT-1 antibodies in the EBCs of the 
SELs, whilst the reactions to GLUT-3 and GLUT-4 were weak or undetectable (Wattle and 
Pollitt, unpublished data). This data was concordant with the work of (Asplin, 2009), 
describing strong GLUT-1 mRNA expression in the lamellae of normal and laminitic ponies, 
and very weak expression of GLUT4 mRNA in the same tissues. The protein GLUT-1 is one 
of the thirteen members of the family of facilitative sugar transporters (GLUT1- GLUT12 
and HMIT) (Wood and Trayhurn, 2003) and is characterized by its insulin-independent 
regulation of glucose uptake in tissues with high metabolic requirements (Ebeling et al., 
1998). (Asplin, 2009) utilizing lamellar explants from healthy horses demonstrated that 
glucose uptake in the lamellar tissue is a process not responsive to insulin and also, glucose is 
capable of modulating its own transport and metabolism in tissues where insulin-dependent 
glucose transporters are not present. Thus, the impairment of glucose uptake by a reduced 
insulin sensitivity or increased IR seems to be an unlikely mechanism explaining the failure 
of the SADP.  
Recently, laminitis was successfully induced in healthy insulin-sensitive ponies and 
horses through treatment with a prolonged euglycemic hyperinsulinemic clamp (p-EHC) 
(Asplin et al., 2007; de Laat et al., 2010a). All treated ponies (Asplin et al., 2007) and horses 
(de Laat et al., 2010a) developed laminitis within 72 and 48 hours, respectively. These 
experiments give a clear indication that hyperinsulinemia itself is a major factor in the onset 
of the disease. The exactly mechanisms by which insulin leads to laminitis are still unclear, 
and different possible pathways has been investigated. Among the main possibilities are: 
effects on blood flow, inflammatory effects, glucoses excess, MMP activations (Menzies-
Gow, 2012) and morphological derangements (de Laat, 2011).  
Vasodilation is a known vascular action of insulin exerted through an endothelium-
derived nitric oxide mediated effect (Steinberg et al., 1994) modulated through the 
phosphatidylinositol 3-kinase (PI-3K) pathway (Kim et al., 2006). A previous study, in which 
hoof wall surface temperature (HWST) was suggested to mirror perfusion within the hoof, 
concluded that horses treated with insulin show increased HWST and therefore vasodilation 
(de Laat et al., 2010a). However, vasodilation alone, provoked using persistent digital 
hyperthermia fails to induce laminitis; therefore it may be involved in the pathogenesis of the 
disease but is not the sole factor (de Laat et al., 2012c). Insulin also modulates 
vasoconstriction through the release of endothelin-1 (ET-1) which is controlled by the 
mitogen-activated protein kinase (MAPK) pathway. In IR subjects the PI-3K activation is 
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blocked and the imbalance of NO:ET-1 favours vasoconstriction (Kim et al., 2006). Field and 
Jeffcott (1989) related the vascular theory of laminitis with hyperinsulinemia through a 
different pathway in ponies. They proposed that hyperinsulinemia and IR increase 
thromboxane A2 release and platelet aggregation, inducing vasoconstriction in the peripheral 
vasculature of the horse and laminitis. However, experiments conducted in horses and ponies 
inducing laminitis utilizing a p-EHC protocol, did not evidence histologic lesions compatible 
with ischemia or procoagulatory conditions (Asplin et al., 2007; de Laat et al., 2010a). It must 
be mentioned that these horses were insulin sensitive and the exactly role of IR on the process 
of laminitis remains unclear.  
Inflammation appears to be a minor characteristic of insulin-induced laminitis. 
Leukocyte infiltration into the dermal tissue of experimental insulin treated horses was milder 
than that reported in horses subjected to ACO models (de Laat, 2011). Obesity and IR, 
conditions found in horses with endocrinopathic laminitis, have been associated with 
inflammation by several authors. Vick et al. (2007) described correlation between elevated 
tumor necrosis factor (TNF) p, mRNA expression of TNFα and obesity. Also, these factors 
were associated with increased circulating concentrations of insulin and reduced insulin 
sensitiveness in mares with high body corporal score and percent of body fat. In addition, 
mares treated with insulin for 6 h experienced increased concentrations of TNFα and IL-6 
(Suagee et al., 2011); supporting the theory that hyperinsulinemia could stimulate 
inflammation. Suagee et al. (2012) demonstrated that non-obese geldings fed with high 
glycemic diets showed increased serum TNF concentrations, proposing that high glycemic 
diets promote inflammation independent of obesity. In another study, peripheral blood cells 
of obese hyperinsulinemic horses showed decreased gene expression of IL-1 and IL-6, 
suggesting that obesity and IR are not associated with a generalized pro-inflammatory state in 
the horse as usually is described in humans (Holbrook et al., 2012). In the horse the acute 
phase protein serum amyloid A (SAA) appears to be the principal acute phase protein. Body 
condition and insulin seems to influence SAA more than the commonly measured pro-
inflammatory cytokines. Hence, SAA has been proposed as a better marker of obesity-
associated inflammation and laminitis risk than are TNF, IL-6 and IL-1β (Suagee et al., 
2013). The presence of Toll-like receptor (TLR), a family of pattern recognition receptors 
crucial in the regulation of non-infectious inflammation, has been confirmed in the lamellar 
tissue (de Laat et al., 2014). TLR signalling activation modulates the release of inflammatory 
cytokines among other inflammation mediators (Yu et al., 2010). Horses treated with a p-
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EHC showed increased lamellar protein expression of TLR4, TNF-α, but no IL-6 (de Laat et 
al., 2014). These results are consistent with the minimal cellular inflammatory response 
observed previously in the insulin-induced model (de Laat et al., 2012b). Although the 
literature supports a correlation between laminitis, obesity, hyperinsulinaemia and 
inflammation, the latter appears to be a consequence rather than an initiating factor.  
The participation of MMPs in the pathogenesis of laminitis has been described in the 
ACO, OF and black walnut extract (BWE) laminitic models (Loftus, 2008; Visser and Pollitt, 
2012). MMP-2 can be found in the normal lamellar tissue and its expression has been found 
to be elevated in the lamellae of horses during the developmental phase of laminitis (Mungall 
et al., 2001). Horses subjected to the OF model had delayed activation of lamellar MMP-2 
and no activation of proMMP-9 relative to the initiation of the basement membrane damage, 
indicating that MMP may not play the initiating role in the lamellar lesion (Visser and Pollitt, 
2012). In contrast, horses subjected to p-EHC showed decreased proMMP-2 at the early 
developmental stage of laminitis (6 h) compared to later time points (24 h) and the acute 
phase (48 h). MMP-9 levels were observed to gradually increase during the developmental 
stage with a marked elevation in the acute phase (de Laat et al., 2011b). The increase of 
MMP-9 is mediated by insulin via the MAPK signalling pathway in monocytes (Fischoeder 
et al., 2007) and may be the explanation for the increase of lamellar MMP-9 found in lamellar 
tissue during hyperinsulinemia (de Laat et al., 2011a). Despite the role of MMPs in the 
developmental stage of insulin-induced laminitis being unclear, MMP activation may be a 
relevant factor at later stages of the disease.  
 
Exposure of tissues to an excess of glucose over prolonged periods of time produces 
glycosylation of proteins and formation of advanced glycation endproducts (AGEs). These 
events play an important role in the progression of diabetic complications in humans 
(Delafontaine et al., 2004) and may be also involved in the pathogenesis of laminitis. The 
lamellar tissue could be susceptible to protein glycosylation and oxidative stress during 
periods of increased glucose metabolism due to its particular glucose uptake regulation 
independent of insulin (de Laat et al., 2012a). Healthy horses subjected to p-EHC for 48 h 
showed accumulation of AGEs and increased GLUT-1 transporter in the lamellar tissue. 
However these changes were not observed at early time-points suggesting that AGEs may be 
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involved in the pathogenesis of insulin-induced laminitis but not as the main cause of the 
disease (de Laat et al., 2012a). 
The presence of mitotic figures and apoptotic cells was a common finding in the 
experimental ponies and horses treated with insulin by Asplin et al. (2007) and (de Laat et al., 
2010a). These proliferative changes were observed during the early stages of the disease and 
are likely to be primarily involved in the pathophysiology of insulin-induced laminitis (de 
Laat et al., 2012b). Insulin via its receptors regulates cellular proliferation and cellular growth 
through different signalling pathways.  The presence of the insulin receptor (InsR) is 
restricted to the lamellar tissue microvasculature; however the Insulin-like growth factor 1 
receptor (IGF-1R), which can be also activated by insulin, is widely distributed in the 
lamellar vascular elements, epithelial cells and fibroblasts (Wattle and Pollit, unpublished 
data; Burns et al, 2012)    and its activation could be responsible for the epidermal cell growth 
and proliferative dysregulation observed in the insulin-induced laminitic model (Burns et al., 
2012; de Laat et al., 2010a). IGF-1R is known to be mitogenic in vivo and in vitro, it 
promotes growth and an increase in size of the cell, it sends a powerful anti-apoptotic signal, 
can induce differentiation in some cell types, and plays a major role in the transformation of 
cells (Baserga, 2000). Considering these effects and the presence of the IGF-1R in the 
epidermal lamellar tissue, it has been suggested that changes observed in the p-EHC horses 
could be the result of insulin stimulation of this receptor (Bailey and Chockalingham, 2010). 
Furthermore, lamellar epithelial cells exposed in-vitro to high concentrations of insulin 
showed increased cell proliferation and when these cells were co-incubated with a blocking 
antibody against the IGF-1R, the proliferative effect of insulin significantly decreased (Bailey 
and Chockalingham, 2010). Hence, the direct proliferative effects of insulin may lead to 
structural derangements and weakening of the lamellar tissue organization resulting in failure 
of the SADP and laminitis (de Laat et al., 2011b).  
1.2.4 Insulin signalling 
 
Insulin is a polypeptide hormone with a molecular weight of 5747.6 Da in the horse. 
It consists of two chains, α and β, of 21 and 30 amino acids respectively that are connected by 
two disulphide bonds (Ho et al., 2011). Insulin structure has been highly conserved 
throughout evolution and exhibits slight differences among species (Conlon, 2001), mainly at 
positions 8, 9 and 10 of the α chain (Martin and Crump, 2003). Insulin is synthesised and 
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secreted in the exocrine pancreas by the β cells mainly in response to increased blood glucose 
levels, although other factors such as increased concentration of some amino acids, fatty 
acids (Aronoff et al., 2004), hormones and neuropeptides among others can stimulate insulin 
secretion (Martin and Crump, 2003).  
 The main function of insulin is related to the control and regulation of glucose 
metabolism (Aronoff et al., 2004). However, insulin has an important role in diverse 
processes such as vascular tone modulation, proliferation, growth and differentiation of cells, 
and its recently suggested neuromodulatory role in the mammalian central nervous system 
(Schulingkamp et al., 2000). Whatever the pathway stimulated by insulin, such stimulation 
must be initiated by interactions with any of its possible receptors: the insulin receptor (InsR) 
and/or insulin-like growth factor 1 receptor (IGF-1R).  
 
1.2.4.1 Insulin Receptor (InsR) 
InsR is widely distributed in different tissues of mammals. The highest expression 
was found in adipose tissue, whilst in liver, heart and lung tissue only 30% was expressed 
relative to adipose tissue. Furthermore, muscle, brain, spleen, placenta and kidney tissue 
expressed only 10% of that found in adipose tissue (Bailyes et al., 1997). Wattle and Pollitt 
(unpublished data), using antibodies against InsR have described the distribution of the InsR 
in the lamellar tissue. The receptor was found in the coronet and blood vessels of the lamellar 
dermis, especially within the small vessels of the secondary dermal lamellae (SDL) adjacent 
to the glucose dependent lamellar basal cells. However, no InsR has been observed in the 
epidermal lamellae (Burns et al., 2012). 
InsR protein is a disulphide-linked (αβ)2 homodimer. The extracellular portion of 
each αβ promoter contains six domains (L1, CR, L2, FnIII-1, FnIII-2 and FnIII-3) and an 
insert domain (ID) within FNIII-2. The α-chain component of the ID is terminated by a 
segment termed αCT (McKern et al., 2006). These segments are important to understand the 
insulin-InsR splicing process. Two different sites of the receptor are described interacting 
with insulin: a low affinity and a high affinity insulin binding site. Insulin binds first to the 
low affinity site (site 1) composed of the αCT fragment of one α-subunit and then to the high 
affinity site (site 2) composed of the L1 fragment of the other α-subunit (De Meyts, 2008). 
The engagement between the insulin molecule and the site 1 of the InsR has been recently 
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described by (Menting et al., 2013), showing in detail the conformational changes of the 
receptor as well as of the insulin molecule. The binding of insulin to the InsR brings the two 
β-subunits into close opposition, activating the InsR tyrosine kinase domain through auto-
phosphorylation, initiating a complex cascade of biochemical signals. Two major signalling 
pathways resulting from the receptor stimulation have been described, phosphoinositide 3-
kinase (PI-3K) and Ras (Belfiore et al., 2009).  
PI-3PKs belongs to a lipid kinases family that catalyses the phosphorylation of 
phosphatidylinositol and phosphoinositides generating new intracellular second messengers 
(Cheng et al., 2012). The protein serine/threonine kinase AKT (also known as PKB) 
activation is directly facilitated by PI-3PK (Belfiore et al., 2009). In muscle and fat AKT 
activation regulates glucose uptake, stimulating the translocation of the glucose membrane 
transporter protein GLUT-4 and the glycogen synthesis (inhibiting the enzyme glycogen 
synthase 3), whilst in the liver, AKT inhibits gluconeogenesis blocking the transcription of 
gluconeogenic enzymes (Cheng et al., 2012). AKT also promotes other process such as cell 
survival and apoptotic modulation. Moreover, through the activation of the regulatory-
associated protein mammalian target of rapamycin (mTOR), AKT regulates cellular growth 
and protein synthesis (Taniguchi et al., 2006).  
The Ras pathway, (also called Ras-MAPK pathway) is activated by insulin following 
the binding of growth factor receptor-bound protein 2 (Grb2) to the insulin receptor substrate 
proteins (IRS). This binding triggers a complex kinase cascade that modulates cell growth as 
well as cellular survival and differentiation (Belfiore et al., 2009).  
 
1.2.4.2 Insulin-like growth factor 1 receptor (IGF-1R) 
IGF-1R belongs to the same family of transmembrane tyrosine kinases that include 
the InsR and the orphan insulin receptor-related receptor (IRR). They share the homodimeric 
structure and domains with slight variations in the amino acid sequences. IGF-1R has a 70% 
homology to the InsR (Baserga, 2000) and also heterodimers InsR/IGF-1R have been 
described in cells expressing both receptors (Schaffer et al., 1993). Three ligands are 
described binding IGF-1R: insulin growth factor 1 (IGF-1), insulin growth factor-2 (IGF-2) 
and insulin (Baserga, 2000). IGF-1 and IGF-2 are produced by the liver and also by other 
extrahepatic tissues such as tumor cells and stromal fibroblasts (Adams et al., 2000). IGF-1R 
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binds IGF-1 with high affinity, whilst insulin (at high concentrations) and IGF-2 bind with 
lower affinity. IGF-2 is involved in the foetal developmental stages and is mainly regulated 
by the IGF-2R (Chitnis et al., 2008).  
IGF-1 is the main ligand of IGF-1R and its plasma levels have been described in 
different species. Several factors such as nutritional status, growth hormone (GH) secretion, 
age, genetic factors, IGF binding proteins, insulin, thyroxine, cortisol, testosterone, estrogen 
obesity and cytokines regulate IGF-1 secretion in humans (Clemmons, 2007). In the horse, 
Champion et al. (2002) described that age plays a significant role in IGF-1 plasma levels, 
with higher concentrations in young animals. In addition, intact males have higher 
concentrations than mares or geldings suggesting a sex effect. Geographic location and level 
of training also played a significant role in the IGF-1 plasma levels.  
IGF-1R shares some of the signalling pathways with the InsR. The PI3K-AKT and 
MAPK pathway are common to both receptors. In some tissues IGF signaling regulates 
cellular differentiation via the PI3K-AKT pathway (Adams et al., 2000), while in others such 
as myocardium and brain PI3K-AKT and MAPK pathways combined are required (Morisco 
et al., 2007; Russo et al., 2005). It plays an important role in growth of normal and malignant 
cells (Chitnis et al., 2008) and is also involved in proliferation, modulation of cell size, 
transformation of cells and cellular adhesion (Baserga, 2000).  
 
1.2.5 Tissue microdialysis 
Tissue microdyalisis is a non-invasive sampling technique developed for studying the 
extracellular fluid (ECF) (Benveniste, 1989). The first attempts to sample the ECF were 
performed by Gaddum (1961) using a “push-pull” technique in brain tissue of dogs. That 
technique used two cannulas, one for pumping liquid directly into the tissue and another to 
withdrawn the liquid. Years later, Bito et al. (1966) implanted “dialysis sacs” into the 
subcutis and brain tissue of dogs. Those sacs contained a mixture of colloidal and saline 
solution and were kept in place for several weeks to then be extracted surgically and 
analysed. From these studies emerged the concept of a “compartment” which can equilibrate 
with the surrounding tissue through a semi-permeable membrane (Ungerstedt, 1991).  In 
early 1970s, hollow fibres were used successfully for sampling ECF in neuroscience at the 
Department of Pharmacology in the Karolinska Institute, (Stockholm, Sweden) (Ungerste.U 
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and Pycock, 1974) and since this initial design, the “microdialysis probe” evolved into the 
technique used today. 
A microdialysis system is constituted by a microdialysis pump, a probe, a tubing 
system and a collection system. The principle of microdialysis is based on the perfusion of a 
fluid throughout a microdialysis probe inserted into the desired tissue that equilibrates with 
the fluid outside of the probe by diffusion through a semipermeable membrane (Ungerstedt, 
1991). In ideal conditions, the perfused fluid should be isosmotic with the tissue, the 
hydrostatic pressure minimal and no net water transfer between the perfused solution and the 
animal tissue should exist: the concentration gradient of the studied substance should be the 
sole driving force of the process (Janle and Kissinger, 1996).   
Recovery is the term used to quantitate the amount of analyte collected in the 
dialysate. Absolute recovery corresponds to the total amount of analyte recovered whilst 
relative recovery (RR) represents the ratio of analyte relative to that of the tissue or solution 
sampled. The recovered volume in µD is irrespective of the membrane surface area, but 
depends on the perfusion speed rate (Janle and Kissinger, 1996). Normally, microdialysis 
pumps allow perfusion speed flow between 0.1 – 5 uL/min. Slow perfusion speeds should be 
selected to allow the perfusion solution and the ECF to equilibrate. Also a slow flow rate 
helps to reduce possible disturbances of the normal tissue physiology (Ungerstedt, 1991). 
Probe outer diameters are usually smaller than 400 µm. This feature permits probes to be 
inserted virtually in any tissue with minimum disturbances to its physiology and normal 
parenchymal structure. Several authors have reported its utilization in subcutis (Dostalova et 
al., 2009; Hagstrom et al., 1987; Jansson et al., 1992; Kaptein et al., 1998; Wientjes et al., 
1998), muscle (Deboer et al., 1991; Deguchi et al., 1991; Hallstrom et al., 1989; Miller et al., 
2011; Mimura et al., 1996; Olausson et al., 2013; Rosdahl et al., 2000; Stallknecht et al., 
1999), liver (Bjornsson et al., 2012; Davies and Lunte, 1995, 1996; Haugaa et al., 2010; 
Takahashi et al., 1996; Vanbelle et al., 1995), brain (Bjerring et al., 2011a, b; Bossers et al., 
2013; Li et al., 2012; Notkina et al., 2012; Sato et al., 2011), adipose tissue (Arner and 
Bolinder, 1991; Jansson et al., 1995; Kopterides et al., 2012; Lourido et al., 2002; Song and 
Lunte, 1999; Summers et al., 1998), and recently in the lamellar tissue of the horse hoof 
(Nourian et al., 2010). Also tissue microdialysis can be used for continuous monitoring for 
time periods ranging from a few hours to several weeks (Wientjes et al., 1998). A fibrotic 
reaction has been described around the probe during prolonged microdialysis experiments 
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and decreased analyte concentrations collected has been associated with this phenomenon 
(Smith and Kaplitt, 2009).  
The recovery of substances from the ECF is dependent on the length (surface area) of 
the dialysis membrane; the flow rate of the perfusion liquid; the diffusion speed of the 
substance through the ECF and the properties of the membrane (Amberg and Lindefors, 
1989; Benveniste, 1989; Bungay et al., 1990; Lindefors et al., 1989). Relative recovery is 
inversely related to the perfusion flow rate, the diffusion is limited due to an increased 
hydrostatic pressure gradient across the membrane (Benveniste, 1989) and also because of  
reduction in time available for the equilibrium of the substance (Lindefors et al., 1989). The 
logical thinking is that the membrane is the main barrier during dialysis; however the ability 
of the substance to diffuse through the ECF plays an important role in both the amount of 
substance that can be recovered and the speed needed to detect concentration changes 
(Ungerstedt, 1991). 
Microdialysis can be used to measure almost any molecule or metabolite able to pass 
across the semipermeable membrane. The pore size of the membrane usually ranges between 
6 and 300 KDa of molecular weight cut-off (MWCO) depending on the size of the molecule 
being studied. Most of the energy metabolites (e.g. glucose, lactate, pyruvate, and urea) and 
small proteins can diffuse across the membrane without problems, however large protein 
diffusion can be difficult. Rosenbloom et al. (2005), using a 100 kDa MWCO probe 
described that the diffusion of large proteins such as ovoalbumin (43 kDa), albumin (66 kDa) 
and transferrin (80 kDa) is considerably affected by the pore size. Published MWCO values 
may not predict the size of the proteins that can be recovered and also protein recoveries 
appear to decrease markedly over time. Small proteins were less affected than large ones; but 
significant differences among proteins similar in size were observed perhaps due to protein 
aggregation, shape, surface charge or hydrophobicity. During sampling of proteins utilizing 
probes with large MWCO, loss of fluid can be experienced (Sjogren et al., 2002). In these 
situations a high molecular weight substance such as dextran should be added to the perfusate 
to maintain osmotic balance.  Rosenbloom et al. (2005) described an improvement of 10% to 
20% in the recoveries of protein utilizing this technique.  
Diverse methods have been proposed to determine the actual concentration of a 
substance in the sampled tissue using microdialysis, among them: difference method or no net 
flux; extrapolation to zero flow; retrograde dialysis and endogenous reference compound. 
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The difference method or no net flux was first proposed by Lonnroth et al. (1987) and 
is based on the principle that if the concentration of the desired substance is the same in both 
the perfusate and the sampled solution, there will be no net transfer between membrane and 
tissue. Using this method several perfusate concentrations have to be tested to find the tissue 
concentrations, being a time-consuming technique (Janle and Kissinger, 1996). As previously 
mentioned, the recovery is inversely related to the flow rate perfusion. In the extrapolation to 
zero flow method, the perfusion speed is set up as slow as possible allowing the sampled 
tissue and the perfused solution to equilibrate. Then concentrations are determined and 
plotted against flow rate and extrapolated to find zero flow rate (Jacobson et al., 1985).  
Retrograde dialysis or retrodialysis is the perfusion of a solution containing a substance 
identical (or as similar as possible) to the target analyte. Assuming that the diffusion across 
the membrane will be the same in both directions (from the perfusate to the tissue and vice 
versa), the loss of the substance perfused can be used to calculate the recovery of the analyte. 
The drawback of this technique is the difficulty in finding a substance whose behaviour 
imitates exactly the analyte without interfering with the experiment. The endogenous 
compound reference technique is based in the utilization of an internal substance as a 
reference to calculate the RR of the desired analyte. The first compound used as an 
endogenous reference was glucose (Hashimoto et al., 1998). Urea has been proposed as a 
possible endogenous reference molecule (Brunner et al., 2000; Schwalbe et al., 2006; 
Strindberg and Lonnroth, 2000) since it is a substance equally distributed in the ECF and its 
concentrations in the tissue are very similar to that of the plasma. This technique is based on 
the assumption that the ratio of RR for two substances either in vivo or in vitro is constant 
over time (Schwalbe et al., 2006). Utilizing urea RR calculated in-vivo and in-vitro, and the 
recovery of the substance of interest in vitro, the in vivo recoveries of the desired substance 
can be determined. Strindberg and Lonnroth (2000) and Schwalbe et al. (2006) demonstrated 
that interstitial concentrations of glucose, lactate and glycerol; and linezolid respectively, 
determined in muscle and subcutaneous tissue of humans using urea as an endogenous 
reference compound were significantly correlated with those using other calibration 
techniques such as retrodialysis. In turn, Brunner et al. (2000) could not determine glucose 
concentration in human muscle ECF using this calibration technique. High variability was 
observed when the technique was compared to no net flux, mainly due to a marked difference 
in the ratio between urea and glucose recovery in vivo and in vitro. Also, performing in vivo 
experiments involves tissue dynamic process and conditions that differ from in vitro 
experiences and can subsequently affect the outcome of the dialysis process. 
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 Tissue microdialysis, besides being a sampling technique, also allows delivery of 
substances to the tissue. Recently microdialysis has been used in neuroscience for delivering 
drugs to the central nervous system (Boehnke and Rasmusson, 2001; Ludvig et al., 1995; 
Osman et al., 2005) and insulin to human skeletal muscle . Rosdahl et al. (2000) assessed the 
changes in the concentration of muscular interstitial glucose, lactate and urea during the 
perfusion of different concentrations of insulin through a 100kDa MWCO probe. The 
ultrafiltration often experienced during dialysis when probes of high MWCO (100kDa) are 
used was successfully solved by the addition of dextran to the perfused solution avoiding the 
loss of fluid to the tissue and therefore maintaining stable recovery volumes. Insulin perfused 
in supra-physiological concentrations led to decreasing glucose levels and increasing lactate 
levels whilst urea remained constant. These changes in the metabolite concentrations were 
determined simultaneously with insulin delivery, supporting the utilization of tissue 
microdialysis for the evaluation of the effects of large peptide molecules such as insulin in 
vivo. 
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1.3 Hypotheses  
We hypothesise that insulin, delivered in higher concentrations than normal into the 
lamellar interstitial fluid, has profound local effects including vasodilation, derangements of  
energy metabolism and induced epidermal cellular proliferation.  It is these local tissue 
effects of insulin that result in laminitis in experimental models and naturally occurring cases 
where hyperinsulinemia is a feature. 
 
1. 4 Aims and Objectives 
Objectives addressing the hypothesis 
 To determine the in vivo effects of local (lamellar) delivery of excess insulin on: 
a. lamellar tissue perfusion  
b. lamellar energy metabolism  
c. lamellar histomorphometry 
d. lamellar epidermal cellular proliferation (mitotic activity) 
Objectives adding background information to studies of laminitis 
 To validate a new technique for determining cellular proliferation rates in the 
equine lamellar tissue. 
 
 
 To characterise the rate of epidermal proliferation in normal hooves. 
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Part II: Experiments 
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Chapter 2: The effect of locally delivered exogenous insulin on 
equine lamellar histomorphometry and epidermal cell 
proliferation. 
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2.1 Summary 
Reasons for performing study: Increased lamellar epidermal cell proliferation and tissue 
disorganization have been described in the hyperinsulinaemic laminitis model. However, it is 
unclear whether these changes are direct effects of insulin.   
Objectives: To determine the effects of locally delivered exogenous insulin on the 
proliferation rate of epidermal basal cells (EBCs) and lamellar histomorphometry. 
Study Design: Randomised, controlled (within subject), experimental trial  
Methods: Both forefeet of eight Standardbred horses were instrumented for tissue 
microdialysis: control limbs were perfused with isotonic polyionic solution, whereas  
recombinant human insulin (100 µg/ml) was added to the perfusate for treated limbs. The 
tissue was perfused continuously at 1 µl/min for 24h. Prior to euthanasia, 60 mg of the cell 
proliferation marker EdU, was administered bilaterally via retrograde intravenous injection 
with a tourniquet placed for 1 h.  Lamellar tissue was harvested from 5 different areas around 
the microdialysis membrane (L1, central; L2, lateral; L3, medial; L4, proximal and L5, 
distal). The total number of epidermal cells (TNC) and the number of EdU-positive epidermal 
cells (TNPC) were counted in 250 fields per section. Histomorphometry measurements 
included length of primary epidermal lamellae (PELL), their keratinized axes (KPELL) and 
non-keratinized tips (NKPELL). 
Results: Histomorphometric differences were found only in L1 sections: means (± SD) of 
PELL were 8% longer in the treated group (5.67 ±  0.18 mm) compared to control (5.26 ± 
0.14 mm) (p < 0.05), as a result of an increased NKPELL (940 ± 124 vs 681 ± 64 µm; p < 
0.05). The total cell number did not differ, but EdU-positive cells (42.50 95% CI 0.78–
2325.37) were more numerous in the treated group compared to controls, with a strong trend 
towards significance (p = 0.07).  L1 had the highest mean count of EdU-positive cells 
compared to other areas.  
Conclusions: Continuous local delivery of exogenous insulin induced changes in lamellar 
tissue morphology, suggesting that insulin may act directly at the lamellar level in laminitis. 
  
26 
 
2.2 Introduction 
Insulin deregulation, a key component of several endocrinopathic conditions, has been 
recently implicated in the development of laminitis [1-3]. Previous research has demonstrated 
that normal horses and ponies subjected to systemically high levels of exogenous human 
insulin using a prolonged hyperinsulinemic euglycemic clamp (pHEC) for 24 to 48 h 
developed laminitis, suggesting that insulin itself (at high concentrations) might be the major 
triggering factor for laminitis [4; 5]. The histologic alterations observed in p-EHC models 
differ from those previously described with the black walnut extract [6; 7] and carbohydrate 
overload models (CHO) [8; 9]. The insulin-induced lamellar lesions are mainly characterized 
by lengthening and narrowing of the secondary epidermal lamellae (SELs) with increased 
mitotic activity of the epidermal basal cells (EBCs) leading to considerable tissue 
disorganization, but with minimal effect on the basement membrane (BM) [4; 10].  
Insulin is central to glucose metabolism, participates in the modulation of vascular 
tone, and has a primary role in general cellular metabolism, proliferation, growth and 
differentiation [11; 12]. Hyperinsulinaemia may lead to over-stimulation of the intracellular 
mitogen-activated protein kinase signaling pathway [10] which is responsible for the 
modulation of cellular proliferation [13], and through this it could affect the EBC 
proliferation rate. However, mitotic figures and increased proliferative activity of the EBCs 
have been found in other models of laminitis, and it is still unclear if this is part of the tissue 
reparation process or a primary direct effect of insulin on the lamellae [10]. It is also possible 
that systemic states such as obesity, insulin resistance and hyperinsulinemia may ultimately 
affect the lamellae indirectly, through the induction of other systemic pathways such as 
inflammation [14; 15].  It is important therefore to establish whether insulin acts directly at 
the local tissue level, or whether it requires systemic interactions in order to cause lamellar 
lesions.  
Also, it has been hypothesized that weight-bearing and mechanical distractions may 
contribute to the histological changes observed in horses treated systemically with 
hyperinsulinaemia. Tissue microdialysis has been used previously as a minimally invasive 
means of local exogenous insulin delivery into target tissues [16; 17]. Local delivery of 
insulin via microdialysis permits the assessment of the insulin effects in a circumscribed area 
of the lamellae preserving the rest of the dermo-epidermal junction intact. This is a major 
advantage of the present model and a novel approach to the study of laminitis.    
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The aim of this study was to determine the effects of supranormal insulin levels 
delivered directly into the lamellar tissue using microdialysis, on lamellar histomorphometry 
and epidermal cell proliferation. 
 
2.3 Materials and Methods 
2.3.1 Animals 
Eight Standardbred geldings (aged 6 to 12 years, weight 420 to500 kg) with clinically 
normal hooves were used in this study. The project was approved by the University of 
Queensland Animal Ethics Committee (approval number: SVS/338/11/UQ) that monitors 
compliance with the Animal Welfare Act (2001) and The Code of Practice for the care and 
use of animals for scientific purposes (current edition).  
 
2.3.2 Tissue microdialysis 
In every horse one forelimb was randomly assigned to the treatment group (n = 8) and 
the contralateral limb to the control group (n = 8). Both fore feet of all horses were 
instrumented with microdialysis probes using a technique previously described [18]. Briefly, 
keratinized tissue was resected from the white line region (on the midline, cranial to the point 
of the frog) to create a hole of 1.5 cm diameter. After bilateral abaxial sesamoid perineural 
anaesthesia and aseptic preparation, a modified (loose hub) 18G x 15 cm-long spinal needle
a
 
was introduced through the white line and advanced proximally (at a ~5˚ angle toward the 
third phalanx) until the tip appeared through the skin above the coronet. A coaxial 
microdialysis probe (CMA 20
b
) was inserted through the needle in order to position the probe 
membrane in the mid lamellar region. Once the probe is placed, the needle is projected and 
removed proximally above the coronet.  The resected defect at the toe was filled with dental 
silicone putty (Ortho-Pak Putty
c
). This introduction technique aimed at positioning the probe 
in the sublamellar dermis, close to the primary epidermal lamellar (PEL) tips. 
Microdialysis solutions were prepared aseptically and stored at 4°C until used. The 
control solution was a commercial polyionic microdialysis perfusion fluid (T1
d
) with the 
addition of urea 20mmol/l and dextran 40 mg/ml (Dextran-70
e
) to prevent perfusate loss [19]. 
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In vitro determinations performed previously in our laboratory (Appendix 1) demonstrated 
that a considerable amount of insulin is lost in the microdialysis system as previously 
described [20]. The mean (range) insulin recovery outside the membrane was 0.5 (0.14 – 1.1) 
% of the prepared perfusate concentration.  
Microdialysis provides a single point source for drug delivery. Drug diffusion and 
equilibration are subjected to the drug concentration gradient in the tissue surrounding the 
probe [21]. As such, the insulin concentration selected aimed to be at least ten times greater 
than that achieved in plasma during previous p-EHC studies [4; 5]. Thus, the treatment 
solution was prepared by adding 28 µl of recombinant human insulin (Actrapid
f
) to 972 µl of 
control solution, achieving a final concentration of 100 µg/ml of human insulin. The 
predicted concentration delivered to the tissue was 0.5 µg/ml.  
In one subject human insulin was replaced by fluorescent FITC-insulin at the same 
concentration and following the same preparation protocol. FITC-insulin has comparable 
biological activity to non-labelled human insulin and has been used previously for the study 
of insulin transport and biological interactions [22; 23]  
Following probe placement every foot in each group received control solution during 
the stabilization period (2h) and during the baseline period (1h). After this, treated and 
control groups were perfused with their respective solutions for 24 h at a flow rate of 1µl/min 
using precision microdialysis pumps (CMA 107
g
). Control and treatment perfusates were 
replaced every 12 h using freshly prepared solutions. 
 
2.3.3 EdU perfusions  
After 24 h of microdialysis perfusion, the horses were sedated with intravenous 
detomidine (Detomo Vet
h
) at 0.01 mg/kg BWT. Both forelimbs were desensitized with 
abaxial sesamoid perineural anaesthesia and rubber tourniquets were applied at the level of 
the fetlock. Retrograde intravenous infusion of 60 mg of EdU
i
 dissolved in 30 ml of 0.9% 
sterile saline solution was performed via the lateral palmar digital vein of each foot. The 
tourniquet was kept in place for 60 minutes and then the horses were killed by I.V. sodium 
pentobarbitone (Lethabarb
j
) administration.  
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2.3.4 Tissue sample preparation 
Both control and treated feet were disarticulated at the level of the 
metacarpophalangeal joint and tissue samples (15×10×5 mm) collected from the dorsal hoof 
wall as follows. A central section (L1) was harvested from the midline at the level of the 
microdialysis membrane. Four more sections were taken from a distance of 15 mm (to the 
centre of the section) medial, lateral, proximal and distal (L2, L3, L4 and L5) from the central 
section. Tissue sections were stained with hematoxylin and eosin (H&E) and periodic acid–
Schiff (PAS) for histomorphometry analysis and duplicate sections were processed unstained 
for click chemistry (Alexa fluor 647 Click iT imaging kit®
k
) and nuclei labelling (Hoechst 
33342
l
). 
 
2.3.5 EdU analysis 
Fluorescence microscopy analysis was performed on a confocal microscope (N1R 
confocal, Nikon
m
). Cells were counted in 250 fields per section at 60X magnification using 
NIS Elements 10.0
m
 software for windows. The number of epidermal cells stained with 
Hoechst 33342 only (TNC) and the number of epidermal cells that stained with EdU and 
Hoechst (TNPC) was determined for each section. 
 
2.3.6 Histology and histomorphometry 
Sections were evaluated by one investigator who was blind to the treatments (AVE), 
and scored for laminitis histopathology according to the scoring system of Pollitt [24].  
Histomorphometry measurements were also performed on sections blinded using software 
(ImageJ 1.48v
n
 and ImagePro Plus
o
, for Windows) following a similar protocol to that 
previously described by de Laat et al. [10]. Briefly, the length of the PELs (PELL), their 
keratinized axis (KPELL) and non-keratinized tip (NKPELL) were measured in the six 
consecutive PELs closest to the microdialysis membrane. Secondary epidermal lamellar 
length (SELL) was measured in 10 consecutive SELs in the axial half of previously described 
PELs.  
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2.3.7 Data analysis 
Data were summarized using mean (Standard Deviation; SD), median (1
st
 and 3
rd
 
Quartiles), minimum and maximum. Data normality was tested using the Shapiro-Wilk 
normality test. Means (± SD) of the normally distributed variables were compared between 
the group using paired t-tests. Statistical significance was declared at p ≤ 0.05. 
For the analysis of TNPC, a zero inflated negative binomial model was used to adjust 
for the inflated zero counts and any overdispersion in the data. For inclusion in the 
multivariable analysis, the associations between explanatory variables and cell counts were 
screened using univariable, mixed effects zero-inflated negative binomial models with horse 
fitted as a random effect.  Explanatory variables with a likelihood ratio p-value ≤ 0.20 were 
selected for the multivariable model. Multivariable modelling process was done using 
forward and backward elimination procedure and statistical significance was declared using 
the likelihood ratio test and an alpha level at 0.05 or less. Two-way interactions were tested 
and model fit was assessed using Pearson goodness-of-fit test. The model was fitted using 
menbreg procedure in Stata (Stata13.1
p
) with unstructured variance-covariance structure of 
the random effects and robust standard errors.   
 
2.4 Results 
2.4.1 Histology and histomorphometry 
The microdialysis membranes were located in the sub-lamellar tissue in the control 
and treated groups at a median distance of 2.03 mm (range 1.17 - 5.86) and 1.86 mm (range 
0.8 - 4.5)  respectively from the tip of the closest PEL and therefore did not directly disrupt 
PEL architecture. There appeared to be some mild laminitis histopathology (grade 1) [21] 
present in the sections immediately surrounding the probe (L1) in the treated limbs. This 
consisted of rounding of EBC nuclei, lengthening and attenuation of SELs and some BM 
separation visible with PAS staining.  Apoptotic cells and mitotic figures were rare in both 
treated and control sections. The median (interquartile range) histological score for the 
treated sections at this level was 1 (0.25-1.75) compared with 0 (0-0.75) in control limbs (Fig. 
2.1), and the difference approached significance (p = 0.0625). At all other section levels the 
median scores for both treated and control limbs were 0 and were not  different.   
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Total number of cells, PELL, KPELL, NKPELL and SELL were normally distributed 
and differences in the histomorphometry measurements between groups reached significance 
only at L1. The PELLs were significantly longer in the treated group (5.67 mm±0.18) 
compared to the control group (5.26 mm ± 0.14; p = 0.034) and NKPELL were longer in the 
treated group (0.94 mm ± 0.124) compared to control (0.68 mm ± 0.064; p = 0.05) (Fig. 2.2 
and 2.3). Comparisons of KPELL and SELL did not reach significance in any of the sections 
(Fig. 2.2).  
In the one treatment limb where FITC-insulin was used in the perfusate, a fluorescent 
area of 277.27 mm
2
 was detected around the microdialysis probe, demonstrating that insulin 
successfully diffused through the microdialysis membrane to the interstitium. 
 
2.4.2 EdU  
The EdU labelled and total cell counts are summarized in tables 2.1. Analysis by a 
zero inflated negative binomial model (Table 2.2) showed that the mean count of TNPC was 
42 (95% CI 0.8 to 2e
3
; p = 0.07) times higher in the treatment group compared with control 
group. Levels 3 to 5 were grouped for comparison purposes as they were not statistically 
different from each other. The mean count of TNPC at L1 and L2 was 25 (95% CI 8.6 to 72; 
p < 0.01) and seven (95% CI 2.2 to 22; p < 0.01) times that of levels 3-5 respectively. No 
significant differences were found in the TNC between groups at any sample level.  
  
2.5 Discussion 
The local delivery of insulin for 24 h affected the histomorphometry of the lamellar 
tissue in the region immediately surrounding the microdialysis membrane. The PELL and 
NKPELL were increased significantly (p < 0.05) only in the central sections (L1) of the 
treated limbs. The combination of longer PELL and conserved KPELL observed exclusively 
in the sections closest to the membrane (L1) in the treated group supports a direct effect of 
insulin contributing to changes in the lamellar tissue, affecting mainly the SELs at the axial 
tips of the PELs (NKPELL).  These effects were absent in control limbs and the amount of 
insulin delivered was too small to affect systemic insulin status, indicating therefore that 
insulin can cause direct alterations to lamellae without the need for systemic interactions. 
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Insulin delivered locally to the lamellar tissue via microdialysis exerted a similar 
effect on the EBCs to that observed when it is administered systemically. Elongation and 
narrowing of the SELs has been described previously in ponies [25] and horses [4] subjected 
to the p-EHC model. de Laat et al. [10] suggested that elongation of the SELs may be related 
to an increase in the total number of epidermal cells, supported by the increased number of 
mitotic figures and the TPX2 immunolocalisation in those tissues after 24h of the p-EHC 
model. Additionally, it was proposed that the loss of normal orientation and shape of basal 
cell nuclei observed may reflect an insulin effect on EBC metabolism and cytoskeletal 
integrity [26]. Karikoski et al. [27] attributed the lengthening and narrowing of the SELs of 
ponies subjected to p-EHC induced laminitis mainly to cell stretching.  Considering that no 
differences were found in the total number of cells between treated and control limbs in the 
current study (Table 2.1), the lengthening of the PELs cannot be explained by an increase in 
the number of cells, and therefore the data supports cell stretching as the means by which 
insulin disrupts lamellar architecture when delivered locally. 
Besides the well described effects of insulin on cellular metabolism, growth and 
proliferation [11], it has been reported that insulin can exert direct effects on the cytoskeleton 
of different types of cells via the insulin receptor (IR) and the insulin-like growth factor 1 
receptor (IGF-1R) [28-30]. Previous studies using cultured rat mesangial cells demonstrated 
rearrangement of the cytoskeleton after exposure to insulin for one hour. The changes 
observed in the lamellae in the present work might be explained by a similar pathway. As 
previously described by Burns et al. [31], the distribution of IR in the lamellar tissue is 
restricted to the vasculature whilst the IGF-1R is ubiquitous. Thus, high local levels of insulin 
may stimulate the EBCs via IGF-1R, affecting the cytoskeleton and subsequently the shape of 
the cells, organization of the organelles and stability of the tissue.  
It is still likely that cellular proliferation plays an important role in the 
pathophysiology of insulin-induced laminitis. Lamellar epidermal proliferation has been 
previously studied by Daradka and Pollitt [32] using the proliferation marker BrdU 
(Bromohydroxiurudine), and by de Laat et al. [26] using TPX2. The novel proliferation 
marker EdU was used in the current study.  EdU is a thymidine analogue which is 
incorporated into the DNA exclusively during the synthesis stage (S) of mitosis, labelling 
only the cells that are actually proliferating [33]. EdU was selected for this study over the 
other markers available because of its good sensitivity and simple protocol for sample 
analysis [34; 35]. Our group has standardized and used this technique (EdU delivered via 
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regional perfusion) for the study of proliferation in normal equine lamellar tissue (Chapter 4), 
with similar results to previous studies [32]. The proliferative response to the local delivery 
of insulin in the current study was not as substantial as described by de Laat et al. [26] for the 
p-EHC. However the number of EdU positive cells in the treated group was 42 times that of 
the control group, with a clear trend toward significance (p = 0.07).  Also, increased 
proliferation was found at L1 (control and treatment groups together) compared to the other 
areas. Although the TNPC in the control group is consistent with the proliferation rate 
previously described for normal horses at the level of the hoof (Chapter 4), the increased 
cellular proliferation detected in the treated group cannot be attributed as the result of local 
insulin effects.  
The fact that the difference in TNPC between groups did not reach significance (p = 
0.07) may be related to the small sample size and the variability in the counts between feet 
within the same group, that could be associated with the labelling technique used in this 
study. The effect of the sample size on counts of positive cells is difficult to predict (can be 
bidirectional i.e. away or towards the null) and cannot be evaluated from the current dataset. 
In the present study, the administered dose of the proliferation marker EdU was lower (60 mg 
per foot) than that used previously (Chapter 4) (75 mg per foot). This small dose difference 
should not have caused a notable effect in the determination of the cell proliferation rate. 
However, cell proliferation at the mid-lamellae is rare or absent [32] and the sensitivity of the 
EdU labelling technique can be modified in a concentration-dependent manner [36; 37]. 
Thus, a higher EdU concentration may be required to detect significant changes in cell 
proliferation in the mid-lamellar region. More replicates would be recommended for future 
experiments.  
One of the histological characteristics of the p-EHC laminitis model is minimal 
disruption of the BM compared to that observed in the oligofructose model [10]. It has been 
hypothesized that weight-bearing and mechanical distraction plays a role in the disruption of 
the BM in p-EHC models of laminitis [4], explaining the differences observed between 
ponies and full sized horses in this model. Interestingly, there was some BM detachment 
noted with local insulin delivery in the current study, appearing to be confined to the sections 
immediately surrounding the microdialysis membrane (and presumably with the highest 
concentration of insulin). This suggests that there were sufficient disruptive forces present in 
the focal area around the membrane to cause BM separation, even in the absence of 
widespread failure of the lamellar attachment as would occur with generalized laminitis.   
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Systemically circulating insulin requires binding to its receptor in the endothelium to 
be transported from the vasculature to the tissues. This process has been described by Yang et 
al. [38] and Wang et al. [39] as the most likely limiting step for insulin delivery. In the case 
of microdialysis, the limiting factors are the concentration of the analyte in the tissue, the 
diffusion coefficient and the tortuosity of the tissue [40]. The estimated concentration of 
insulin delivered using microdialysis to the lamellae in this experiment exceeded the 
concentrations described previously that achieved a biological effect in rat brain [16] and 
human muscle [17]. The effect on cellular proliferation in the experiment was only slightly 
outside the significance level (p = 0.07). A concentration-dependent increase in mitotic 
activity has been reported in cultured lamellar epithelial cells incubated for 3 days with 500 
µIU/ml (0.017 µg/ml) of insulin [41]. In that study, EBCs exposed to insulin increased their 
proliferative activity by more than 50% compared to controls. Examination of concentrations 
of insulin in the tissue harvested in the current study was not performed, but would be 
required to confirm the existence of an apparent concentration-response relationship. The 
substitution of regular human insulin with FITC-insulin in 1 horse in the current study 
allowed confirmation that insulin was diffusing out of the membrane into the lamellar 
interstitium, being readily detected by fluorescent microscopy [22]. 
Time of exposure of the tissue to insulin is a relevant factor to consider when 
assessing the effects of insulin on cellular proliferation. In previous experiments by de Laat et 
al. [26], horses treated with p-HEC did not show variation in the proliferation rate after 6 h 
and 12 h of hyperinsulinemia, whilst the expression of the proliferation marker TPX2 
increased significantly after 24 h and 48 h. In the current study, the EdU labelling technique 
only detected cells entering the S phase of mitosis during the 1 h retrograde intravenous 
infusion period of exposure, and this may explain why the total number of proliferating cells 
reported here was lower than that described by de Laat et al. [10] after 48h of 
hyperinsulinemia. Despite this, a clear trend of increased proliferative activity was detected in 
the treatment group. A longer insulin perfusion period, or adjustment of the EdU protocol, 
might be required to confirm a time-dependent effect of insulin on EBC proliferation.  
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2.6 Conclusion 
Lamellar tissue morphology is affected by continuous local delivery of exogenous 
insulin, and although EBC proliferation processes are triggered, the morphological changes 
appear to precede any increase in EBC numbers. Insulin appears to be capable of directly 
acting on lamellar tissue without the requirement for systemic interactions, and these direct 
effects may be responsible for the lamellar changes seen in endocrinopathic laminitis. 
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Table 2.1: Mean (SD), Median (Range) values of total number of epidermal cells (TNC) 
labelled using Hoechst 33342 and total number of proliferating positive cells (TNPC) labelled 
using EdU, counted in five different areas of lamellar tissue (L1 to L5) of control (n=8) and 
treated limbs (n=8) from the hooves of horses dialysed with recombinant human insulin for 
24h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*total cells count × 1000  
 Control Treatment 
 Mean (SD) Median (Range) Mean (SD) Median (Q1, Q3) 
TNC*     
L1 21 (6) 20 (16-24) 21 (6) 22 (18-27) 
L2 23 (6) 24 (19-25) 21 (7) 22 (19-27) 
L3 19 (2) 19 (17-20) 23 (7.0) 231 (19-30) 
L4 22 (4) 21 (20-24) 21 (7) 21 (15.-27) 
L5 21 (6) 20 (18-25) 24 (7) 27 (18-29) 
TNPC     
L1 1.9 (3.6) 0 (0-9) 9.8 (18.3) 0 (0-45) 
L2 0.4 (1.1) 0 (0-3) 6.0 (9.3) 1 (0-14) 
L3 0.4 (1.1) 0 (0-3) 2.9 (5.0) 0 (0-5) 
L4 0.1 (0.4) 0 (0-1) 9.5 (20.1) 0 (0-12) 
L5 0.0 (0.0) 0 (0-0) 1.6 (3.0) 0 (0-5) 
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Table 2.2: Regression coefficients from a zero inflated negative binomial model of the total 
number of EdU positive epidermal cells (TNPC), counted in five different areas of lamellar 
tissue of control (n=8) and treatment limbs (n=8). 
Explanatory variable Coefficient (SE) Mean count ratio (95% CI) P-value 
Group    
Control Reference - - 
Treatment 3.8 (2.0) 43 (0.8 – 2e3) 0.07 
Lamellar area    
    3-5 Reference - - 
1* 3.2 (0.5) 25 (8.6 – 72) <0.01 
2 1.9 (0.6) 7 (2.2 – 22) <0.01 
Key: SE standard error; CI confidence interval. 
Overdispersion parameter was 2 (0.2); 95% CI 1.3 to 2.7; p<0.01; Horse-level random effect 
coefficient was 2.6e-29 (SE 3.7e-29) and 95% CI of 1.65e-30 to 4.13e-28 
*Interpretation:  after accounting for the effect of other variables in the model, the mean 
count ratio of positive cells at level one was 25 (95% CI 8.6 to 72]) times that of areas 3-5 (p 
< 0.01). 
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Figure 2.1: Histological scores for L1.  The median (Interquartile range) score for the 
treatment sections at this level was 1 (0.25-1.75) compared with 0 (0-0.75) in controls. 
However the difference was not significant (p=0.0625).  There were no significant 
differences for the other section sites. 
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Figure 2.2: Mean ±SEM measurements of histomorphometric parameters of five lamellar 
tissue areas (L1 to L5) for control (grey bar, n = 8) and treatment (black bar, n = 8) groups. 
The lengths (µm) of the primary epidermal lamellar (PELL) and the non-keratinized tip of the 
primary epidermal lamellar (NKPELL) were significantly longer only at L1 in the treated 
group. The length of the keratinized axis of the primary epidermal (KPELL) did not differ 
between groups. Significant difference defined as p < 0.05. * = significant difference between 
treatment and control group for that area.  
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Figure 2.3: Photomicrographs of treated (left) and control (right) sections of area L1 (closest 
to the microdialysis membrane) from the same horse showing the histomorphometric 
measurements performed. There is a greater PELL caused by a longer NKPELL in the treated 
foot compared to the control foot. (PELL: primary epidermal lamellar length; KPELL: 
keratinized axis of the primary epidermal lamellar length; NKPELL: no keratinized tip of the 
primary epidermal lamellar)  
  
PELL 
KPELL 
NKPELL 
PELL KPELL 
NKPELL 
45 
 
Chapter 3: The effect of locally delivered exogenous insulin on 
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3.1 Summary 
 
Reasons for performing study: Hyperinsulinemia appears to be central to the 
pathophysiology of endocrinopathic laminitis, however the direct effects of insulin on hoof 
lamellar tissue have not been studied. 
Objectives:  To determine the effects of locally delivered exogenous insulin in vivo on 
lamellar tissue perfusion and energy metabolism using tissue microdialysis. 
Study Design: Controlled (within subject) experimental trial 
Methods: Both forefeet of six Standardbred horses were instrumented for tissue 
microdialysis: control limbs were perfused with isotonic polyionic solution, whereas human 
insulin (100 µg/ml) was added to the perfusate for contralateral limbs.  The tissue was 
perfused continuously at 1 µl/min for 24 h.  Dialysate was collected hourly and metabolite 
concentrations (glucose, lactate, pyruvate and urea) were measured immediately. At the end 
of the experiment the horses were euthanized and tissue samples collected for routine 
histology.  
Results: No significant differences were found in the area under the curve (AUC) of 
metabolite concentrations between groups after the delivery of insulin via microdialysis for 
24 h. Although decreased glucose concentrations and smaller AUC were detected in five out 
of six treatment limbs during the period from 9 to 24h compared to control, the differences 
between groups were not significant (p=0.17). Insulin diffusion into the tissue was confirmed 
by fluorescent FITC-insulin. No differences were found in urea clearance between groups.  
Conclusions: No significant effects were detected in lamellar glucose metabolism or local 
perfusion after 24 h of insulin delivery via microdialysis; however the apparent effects of 
insulin on glucose concentration in all but one horse warrant further investigation. 
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3.2 Introduction 
The development of laminitis as a result of endocrine influences, a phenomenon 
known as endocrinopathic laminitis [1] has received special research interest in recent years. 
Described as the most common form of the disease [2], endocrinopathic laminitis has been 
associated with obesity, consumption of lush pastures, pathologies producing high levels of 
glucocorticoids, and insulin resistance (IR) [3-6]. The common factor in these conditions 
appears to be the development of hyperinsulinemia [7; 8]. Several authors have assessed the 
role of insulin in laminitis [9-16], and the disease has been induced experimentally using a 
prolonged euglycemic hyperinsulinemic clamp (p-EHC) [17] [18].  This supports a direct 
effect of insulin on lamellar tissue rather than any systemic metabolic dysregulation, although 
the mechanism by which hyperinsulinemia causes laminitis remains unclear.     
Insulin is a polypeptide hormone with a well described role in the control of glucose 
metabolism [19]. Nonetheless via the insulin receptor (InsR) and insulin like growth factor 1 
receptors (IGF1R) it also plays a crucial role in the modulation of vascular tone, cell 
proliferation, growth and differentiation [20]. Stimulated epidermal basal cell (EBC) division 
and/or disturbances of cellular energy metabolism may result in weakening or dissolution of 
hemidesmosomes, the vital connections between EBC and their basement membrane, as 
previously described in laminitis models [21-23]. In addition, persistent digital hyperthermia 
occurring during the p-EHC model is suggestive of an effect on digital vascular perfusion, 
which could play some role in laminitis development [17]. Thus, the study of the direct 
metabolic and vascular effects of exogenous insulin on the lamellar tissue is required. 
Tissue microdialysis is a minimally invasive technique that has been used for the 
study of the energy metabolism in different tissues including muscle [24], subcutis [25; 26] 
and equine lamellar tissue [27]. By adding urea to the perfusate, urea clearance can be used as 
an estimate of local tissue perfusion [27-30].  Although microdialysis is traditionally used as 
a sampling technique, it can also be used simultaneously for the delivery of substances into 
the tissue.      McNay et al. [31] and Rosdahl et al. [24] have assessed the effects of locally 
delivered exogenous insulin on the energy metabolism of human muscle and rat brain,  
respectively, using tissue microdialysis. Using similar techniques, the aims of the current 
study were to determine the effects of locally delivered exogenous insulin on lamellar 
perfusion and glucose metabolism. 
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3.3 Materials and Methods 
 
3.3.1 Animals 
Six Standardbred geldings (aged 6 to12 years, body weights of 420 to 500 kg) with 
clinically normal hooves were used for this study. The project was approved by the 
University of Queensland Animal Ethics Committee (approval number: SVS/338/11/UQ) that 
monitors compliance with the Animal Welfare Act (2001) and The Code of Practice for the 
care and use of animals for scientific purposes (current edition).  
 
3.3.2 Tissue microdialysis  
Both fore feet of all horses were instrumented with microdialysis probes using a 
previously described technique [27]. Briefly, keratinized tissue was resected from the white 
line region (on the midline, cranial to the point of the frog) to create a 1.5 cm diameter hole. 
After bilateral abaxial sesamoid nerve block using 2% mepivacaine
a 
and aseptic preparation a 
modified (loose hub) 18G x 15 cm long spinal needle
b
 was introduced through the white line 
and advanced proximally (at a ~5˚ angle toward the third phalanx) until the tip appeared 
through the skin above the coronet. A coaxial microdialysis probe (CMA 20
c
) was inserted 
through the needle in order to position the probe membrane in the mid lamellar region.  The 
resected defect at the toe was filled with dental silicone putty (Ortho-Pak Putty
d
). This 
introduction technique aims at positioning the probes in the sublamellar dermis, close to the 
primary epidermal lamellar (PEL) tips. 
In every horse one forelimb was randomly assigned to the treatment group (n=6) and 
the contralateral limb to the control group (n=6). Microdialysis solutions were prepared 
aseptically and stored at 4°C until used. The control solution consisted of a commercial 
polyionic microdialysis perfusion fluid (T1
e
) with the addition of 20 mmol/l urea for the 
calculation of urea clearance, and 40 mg/ml dextran (Dextran-70
f
) to prevent perfusate loss 
[32]. The treatment solution was prepared by adding recombinant human insulin (Actrapid
g
) 
to the control solution to obtain a final concentration of 100 µg/ml. Preliminary studies in 
vitro (Appendix 1), evidenced high variation in insulin recoveries depending on the 
concentration prepared. Considering this, a concentration of 100 µg/ml was selected to ensure 
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that similar concentrations to previously described (0.035 µg/ml) [18; 33] were achieved. In 
one of treated limbs, human insulin was replaced by fluorescently-labelled FITC-insulin
h
 
following the same preparation protocol.  
Every foot received control solution during the initial stabilization period (2 h) and 
during a subsequent baseline period (1 h). After this, treatment and control feet were perfused 
with their respective solutions for 24 h at a flow rate of 1 µl/min using precision 
microdialysis pumps (CMA 107
i
). Control and treatment perfusates were replaced every 12 h 
with freshly prepared solutions. 
 
3.3.3 Sampling 
After probe placement, a 2 h stabilisation period was allowed before the collection of 
a baseline sample (dialysate) in both groups.  Dialysate samples were then collected hourly 
for a further 24 h and metabolite concentrations (glucose, lactate, pyruvate and urea) 
determined immediately using a commercial microdialysis analyser (Iscus Flex
j
).  Standard 
indices of energy metabolism (lactate:glucose (L:G) and lactate:pyruvate (L:P) ratios) were 
calculated. 
At the end of the perfusion period the horses were euthanized using pentobarbital 
sodium 20 mg/kg I.V. (Lethabarb
k
). Mid-dorsal lamellar tissue samples were harvested at the 
level of the membrane, fixed and stained with hematoxylin and eosin (H&E) for confirmation 
of microdialysis membrane position. The distance (median [IQR]) from the centre of the 
dialysis probe to the tips of the 5 closest PELs was calculated using NIS Elements 10.0
l
 
software for windows. The presence of FITC-insulin in the tissue was detected using 
fluorescence microscopy analysis on a confocal microscope (N1R confocal
m
)  
 
3.3.4 Data analysis 
The area under the curve (AUC) of dialysate glucose metabolites and their ratios 
(lactate:glucose (L:G) and lactate:pyruvate (L:P)) as well as urea concentrations was 
calculated for three periods: baseline to 24 h, baseline to 8 h and 9 to 24 h. 1. The data 
were partitioned into separate time periods rather than taking an average over the entire 
infusion period as it was clear from a visual appraisal of the graphs that there was an initial 
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period of change, followed by a period of stability, which was consistent across all 
metabolites. Similarities in the variance between groups were tested using F-tests. The 
distribution of the data was assumed to be normal because the small size of the data set 
precluded any meaningful normality testing (e.g. Shapiro Wilk test).Then, the AUC of every 
metabolite was compared between groups using paired t- tests. 
Median metabolite concentrations/ratios were calculated and correlated with the 
distance between the microdialysis membrane and the closest PELs in each foot using 
Spearman’s rank coefficients.  
The statistical analysis was performed using GraphPad Prism v6.00 for Windows
n
. 
Statistical significance was set at p < 0.05. 
 
3.4 Results 
 
3.4.1 Histology 
The microdialysis probe membranes were confirmed to be located in the sub-lamellar 
dermis in the control and treated groups at 2.03 mm (1.54 to3.56 mm) and 1.86 mm (1.60 to 
1.96 mm) respectively from the tip of the closest PEL, minimally affecting the normal tissue 
organization.  Evaluation of the FITC-insulin
h
 perfused limb evidenced an area of 277 mm
2
 
fluorescent to FITC, confirming that the insulin was diffusing into the lamellar interstitium. 
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3.4.2 Glucose metabolites 
Median metabolite concentrations for the entire 24 h period are summarised in table 
3.1 and figure 3.1. The analytes concentrations fluctuated during the first 8 h reaching stable 
concentrations during the 9 to 24 h period (Fig. 3.1). Differences in the AUC of the analytes 
between groups failed to reach significance during the baseline to 24 h, baseline to 8 h or 9 to 
24 h periods (table 3.2). However, individual AUC and glucose concentration remained 
considerably lower in horses 3, 4 and 6 over the entire 24 h period. Additionally, five out of 
six horses showed markedly decreased glucose levels and smaller AUC in the treated group 
in the period 9 to 24h compared to control.  Horse number five showed higher glucose 
concentrations and AUC in the treated foot compared to the control over the baseline to 24 h 
and 9 to 24 h periods (table. 3.3 and fig. 3.2). 
 
3.4.3 Urea clearance 
No differences were detected in urea AUC between treated and control feet over the 
24 h, baseline to 8 h  or 9 to 24 h periods. 
 
3.4.4 Correlations 
A trend towards a significant positive correlation (r = 0.9; p = 0.083) was found in the 
treated group between dialysate glucose concentration and the distance from the 
microdialysis probe to the 5 closest PEL, whilst a trend towards negative correlation (r = -0.9; 
p = 0.083) was found between the L:G ratio and this distance, both outside of the significance 
limit. No correlations were found between dialysate glucose concentration and the distance 
from the microdialysis probe (r = 0.2; p = 0.916) nor the L:G ratio and this distance (r = -0.2; 
p = 0.916) in the control group. 
 
3.5 Discussion  
After 24 h of insulin delivery via microdialysis, no significant effects on glucose 
metabolism or local perfusion were detected. Glucose transport in lamellar tissue has been 
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described as an insulin-independent process (at insulin concentrations up to 300 µIU/ml) 
mediated mainly by the glucose transporter GLUT-1 [34]. In vitro experiments demonstrated 
that the expression of this transporter seems to be controlled by the amount of glucose 
available in the medium and that it is also capable of increasing glucose uptake to supra-
physiological levels before saturation [34]. However, the presence of other (insulin-sensitive) 
glucose transporters in the lamellar tissue has not been discounted.  The concentration of 
insulin achieved in the present study appeared to be insufficient to elicit a significant effect 
on lamellar vascular tone. However, it has been recently demonstrated that lamellar perfusion 
is highly influenced by limb movement and the lack of load cycling in the standing, static 
horse may outweigh any vasomodulatory effect of insulin [35].  
Tissue concentrations of insulin measured in human skeletal muscle and subcutaneous 
tissue have been reported to be approximately 50% of the plasma concentration [36; 37]. 
Insulin determinations have not been performed in the lamellar tissue of healthy nor laminitic 
horses and insulin transport from or to the lamellar vasculature has not been described. 
Insulin concentration in the lamellar tissue was not measured in the current study, however 
based on the in vitro calibration of the microdialysis system (Appendix 1), the median (range) 
concentration of insulin expected outside of the membrane was estimated as 0.5 (0.14 – 1.1) 
% of the prepared solution.  Microdialysis provides a single point source for drug delivery. 
Drug diffusion and equilibration are subjected to the drug concentration gradient in the tissue 
surrounding the probe [38]. As such, the insulin concentration selected aimed to be at least 
ten times greater than that achieved in plasma during previous p-EHC studies. Mathematical 
models have estimated that the diffusion radius of a neurotransmitter around a microdialysis 
catheter in the brain could be up to 0.85 ± 0.25 mm depending on the concentration of the 
analyte in the tissue, the diffusion coefficient and the tortuosity of the tissue [39]. 
Additionally, histological analysis of lamellar tissue from the horse perfused with FITC-
insulin
h
 confirmed that insulin was present in the lamellar insterstitium, outside the probe 
membrane. Although FITC-labelled insulin was observed outside the membrane in one limb, 
a more accurate determination of the insulin concentration and distribution in the lamellar 
tissue should be performed. The measurement of the down-regulation of the different insulin 
receptors and the use of immunohistochemistry techniques for the localization of the insulin 
molecules in the tissue should be considered for future studies. 
Although local insulin delivery did not cause a statistically significant difference in 
glucose concentrations, the AUC of glucose concentrations in 5 of 6 horses was consistently 
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lower in the treated group compared to control during the 9 h to 24 h period. In the absence of 
any change in local perfusion (no change in urea clearance) and the lack of any significant 
increase in L:P (a marker of ischemic/non-ischemic bioenergetic failure [40-42]) the most 
likely explanation proposed for the apparent decrease in dialysate glucose concentration is 
increased cellular glucose uptake and consumption. The relatively high consumption of 
glucose by the equine digit as a whole has been demonstrated previously [43]. The lamellar 
dermis is constituted mainly of connective tissue, nerves and blood vessels with limited 
metabolic activity [43], whereas the EBCs are metabolically active and require a continuous 
supply of glucose to maintain cellular functions including the dermo-epidermal connection. 
Pass et al. [44], previously demonstrated in vitro that glucose is crucial for maintaining 
hemidesmosomes in order to resist lamellar separation. Thus the fall in the glucose levels 
with no changes in perfusion (no changes in urea clearance) observed in this experiment 
might reflect an increased glucose uptake by the EBCs possibly stimulated by insulin.  
At normal physiological concentrations insulin exerts its effects via the InsR. In the 
lamellar tissue InsR distribution is restricted to the vasculature, being absent in the EBCs. 
However, insulin at high concentrations is capable of stimulating the IGF1R, which is 
ubiquitous in the lamellar tissue and therefore present in the EBCs [45]. Recently, 
dysregulation of epidermal cell growth and division through activation of IGF1R has been 
suggested as a potential mechanism for the laminitis lesion associated with hyperinsulinemia 
based on the increased proliferative activity and morphological derangements of the EBCs 
observed during the developmental stage of insulin-induced laminitis [47]. In previous 
studies, cultured lamellar epidermal epithelial cells incubated with insulin showed a 
concentration-dependent increase in cell proliferation which was significantly inhibited when 
the IGF1R was blocked [48]. The insulin-IGF1R interaction can activate multiple signalling 
pathways, affecting proliferation and cellular metabolism [49]. For example, the pathways 
PI3K, AKT and mTOR, modulate glucose uptake, glycolysis, fatty acid, protein and 
nucleotide synthesis and also interact with each other to coordinate the cellular state and 
metabolism [49].  
Additionally, it has been demonstrated that an increase in temperature can lead to 
increased cellular metabolic rate and therefore energy cellular consumption [50].  Although 
tissue temperature was not measured in the current study, an increase in the hoof wall 
temperature during the p-EHC laminitis model, possibly associated with vasodilation, has 
been previously reported [51]. Vasodilation is a well described effect of insulin, modulated 
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by the PI-3K pathway [52] and exerted via nitric oxide on the endothelium [53]. Although no 
vascular changes (no changes in urea clearance) were observed in the present study, insulin 
could modulate lamellar arterio-venous anastomosis (AVAs) in particular, without a 
detectable effect on urea clearance.  The opening of AVAs could increase tissue temperature 
and increase cellular metabolic rate indirectly. Thus, the lower concentrations of interstitial 
glucose observed in the treated group might be the result of a metabolic shift of the EBCs 
triggered by insulin, modifying the cellular energy requirements indirectly through the 
stimulation of cellular metabolism, growth and/or proliferation.  
Decrease in glucose levels were observed in some of the control feet along time. 
Interstitial glucose levels depend on local perfusion and glucose uptake by the tissue. 
Lamellar perfusion is highly influenced by limb load cycling activity and should be 
considered when the horses are kept in stocks, as reduced limb load cycling frequency has 
been previously associated with reduced lamellar perfusion [54]. Inflammation can also 
influence tissue glucose levels via local hyperaemia and migration of inflammatory cells to 
the target tissue. A mild inflammatory reaction has been observed in the lamellar tissue 
surrounding the probe with a cellular predominance of neutrophils [27] influencing interstitial 
glucose levels particularly during the period baseline-8h. Variation in the glucose levels 
within group were minimal being the differences between control and treatment limb more 
relevant.   
Some of the limitations of the microdialysis technique observed in this study include 
the variability between horses in the location of the probes placed in the lamellar tissue and 
the actual sampled/perfused area. The proximity of the membrane to the EBCs or to the bone 
surface might alter the metabolite concentrations due to a metabolic gradient between the 
dermis and epidermis. In addition, this distance could also affect the amount of insulin 
reaching the EBCs and their response to the insulin stimulus. The correlations observed in the 
treated group between the levels of glucose and the L:G ratio and the distance from the probe 
to the PELs support the idea that the insulin effect is affected by the proximity of the 
microdialysis probe to the EBCs and therefore the insulin concentration reaching the 
epidermis. The proximity of the membrane to the dermal vasculature must be also 
considered. Wang et al. [55] described the transport of the insulin molecule from vasculature 
to muscle in dogs, demonstrating that the InsR is required by the endothelial cells to transport 
insulin from the blood stream to the tissues. The lamellar dermis is highly vascularized and 
the lamellar capillaries are capable of expressing the InsR, which might result in the removal 
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of the insulin molecule from the tissue, possibly affecting the insulin diffusion and 
distribution in the lamellar tissue.  The high coefficient of variation observed in the AUC of 
glucose of the treated group (60.88) is likely a consequence of the analyte concentrations of 
horse five, which showed a larger AUC in the treated foot compared to the control. 
Concentrations of the other metabolites of control and treatment feet determined in horse five 
were similar to that of the other horses. As glucose cannot be stored within the hoof [43], the 
tissue concentrations of glucose will depend on the local perfusion and on the amount of 
glucose consumed by the tissue.  
In conclusion, local delivery of insulin did not cause significant detectable effects on 
lamellar perfusion or glucose metabolism. However, the apparent decrease in interstitial 
glucose concentration observed in five out of six treated horses during the 9 to 24 h period, 
deserves further research. Increased glucose uptake by the EBCs may occur as a consequence 
of insulin modulation of cellular metabolism via stimulation of IGF1R rather than InsR. 
Insulin dynamics in lamellar tissue warrant further study.  
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3.6 Manufacturers 
a
 Nature Vet, Glenorie, NSW, Australia 
b
 Becton Dickson Infusion Therapy Systems Inc., Sandy, Utah, USA 
c, e, i, j 
CMA Microdialysis, Sweden 
d
 Hoof-Life, Baltimore, MD, USA  
f, h 
Sigma-Aldrich, NSW, Australia  
g
 NovoNordisk, Denmark  
k
 Virbac Animal Health, Milperrin, NSW, Australia  
l, m 
Nikon, Konan, Minato-ku, Tokyo, Japan 
n
 Graphpad Software Inc., La Jolla, CA, USA 
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Table 3.1: Median [±IQR] of metabolite concentrations in the forelimbs of horses perfused 
with a control solution or recombinant human insulin over 24 hours. 
   Treatment Control 
Glucose 0.57 [0.31 - 0.78] 0.74 [0.6 - 1.01] 
Lactate 1.37 [0.97 - 1.49]  1.25 [1.1 - 1.32]  
Pyruvate 48.7 [41.55 - 53.80] 47.7 [34.08 – 55.55] 
Urea 14.65 [13.37 - 15.70] 14.42 [13.68 - 15.87] 
L/G 2.36 [1.34 – 5.23] 1.49 [1.29 – 1.88] 
  
64 
 
Table 3.2: Mean and Coefficient of Variation (CV%) of  the Areas Under the Curve of  
Glucose, Lactate, Pyruvate, Urea, and Lactate to Glucose and Lactate to Pyruvate ratios, 
measured in over 24 h in control (n = 6) and treated (n = 6) feet. 
 
  
 Period 
 
Baseline-8h 9-24h Baseline-24h 
 Treatment Control Treatment Control Treatment Control 
Glucose       
Mean 5.70 7.19 8.304 12.85 14.61 20.83 
CV % 37.1 26.25 60.88 23.04 45.61 21.19 
p value 0.3 0.2 0.17 
Lactate       
Mean 10.7 10.89 19.03 17.15 31.06 29.27 
CV % 33.05 10.56 18.08 12.18 20.65 9.93 
p value 0.9 0.24 0.45 
Pyruvate       
Mean 489.3 498.9 674.4 654.8 1212 1199 
CV % 21.14 20.85 19.67 26.10 15.28 23.53 
p value 0.89 0.79 0.92 
Urea       
Mean 109.3 107 219.3 220.5 343.5 342.7 
CV % 13.99 9.50 8.47 8.78 10.17 8.62 
p value 0.71 0.82 0.94 
L:P       
Mean 184.3 198.8 443.2 430.4 655.8 659.7 
CV % 26.07 16.83 18.19 25.35 11.92 22.20 
p value 0.56 0.78 0.94 
L:G       
Mean 18.73 13.3 118.5 23.51 140.4 38.72 
CV % 63.76 27.13 154.99 22.43 137.36 21.69 
p value 0.33 0.26 0.25 
65 
 
Table 3.3 Areas under the curve for glucose concentration versus time in the hooves of 
individual horses perfused with electrolyte solution (control n=6) or recombinant human 
insulin (n = 6) for 24 hours. Values are Measn and Coefficient of Variation (CV%).  
 Baseline-8h 9-24h Baseline-24h 
Horse Treatment Control Treatment Control Treatment Control 
1 8.105 5.46 7.84 11.45 16.91 17.41 
2 7.43 5.275 8.07 9.33 15.97 15.11 
3 2.57 6.45 2.925 15.29 5.715 22.4 
4 3.85 7.885 4.1 16.37 8.275 25.26 
5 6.05 7.76 17.19 10.03 24.18 18.8 
6 6.205 10.32 9.7 14.64 16.59 26.01 
Mean 5.702 7.192 8.304 12.85 14.61 20.83 
CV % 37.1 26.25 60.88 23.04 45.61 21.19 
p value 0.3 0.2 0.17 
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Figure 3.1: Median ±IQR concentrations of glucose, lactate, pyruvate, urea, lactate-glucose 
ratio and lactate-pyruvate ratio vs. time in the forelimbs of horses perfused with a control 
solution or insulin for 24 h. Glucose concentration decreased progressively in remaining 
below baseline until the end of the experiment; however this difference was not statistically 
significant. No significant differences were found between groups in the other metabolites. 
different from baseline.  
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Figure 3.2: Glucose concentration of the horses (1 to 6) perfused with control and human 
insulin solutions for 24 h via tissue microdialysis. Concentrations in the treatment feet of 
horses 2, 3, 4 and 6 remained lower than control feet over the 24 h period. In all horses but 
number 5, glucose concentrations in the treatment feet remained below the control feet 
between 9 and 24 h. Horse 5 showed higher glucose concentrations in the treatment group. 
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4.1 Summary 
Reasons for performing study: A simple and sensitive method is required to study cellular 
proliferation in the equine hoof. Characterization of normal cellular proliferation is crucial to 
understanding normal growth processes of the hoof and their implications for laminitis. 
 
Objectives: To develop a simple technique for the study of cellular proliferation in the equine 
hoof and characterize epidermal proliferation rates in the normal equine foot using a regional 
delivery technique.    
 
Methods: 5-ethynil-2’-deoxyuridine (EdU) was administered to one of the forefeet of 5 
Standardbred horses using regional intravenous infusion (RIVI). After 60 min with a 
tourniquet in place, horses were euthanized, tissue harvested and EdU detected by click 
chemistry. Tissue sections were analysed using confocal fluorescent microscopy. Total cells 
were digitally counted and a proliferative index (PI%) was calculated for transverse coronary, 
terminal and sole  tubular epidermis, frontal lamellar sections and ten transverse levels of  
dorsal hoof wall lamellae.  
 
Results: Proliferative activity was restricted to the coronet (coronary tubules) PI% =23.97 
(±1.50); terminal 9.58 (±0.66) and sole 6.02 (±0.29) tubules and proximal lamellae 4.01 
(±0.54). Proliferation was rare or absent at middle L5=0.16 (±0.02) and distal lamellae 0.07 
(±0.01). 
 
Conclusions: EdU labelling via RIVI is an alternative technique for the study of cellular 
proliferation in the equine hoof. EBCs actively proliferate at the coronet; proximal lamellae; 
coronary, terminal and sole epidermis but not in the main lamellar region. This technique 
may be especially useful for the study of epidermal basal proliferative disorders related to 
laminitis. 
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4.2 Introduction 
The stratum lamellatum consists of interdigitating dermal and epidermal layers closely 
attached to each other to form the dermo-epidermal junction. The dermal side contains 
nerves, vasculature and a dense matrix of connective tissue, whilst the epidermal side is lined 
by a layer of basal cells and deeper layers of parabasal cells attached to a cornified lamellar 
axis [1].  
Understanding of the growth and repair process of the hoof wall is incomplete. Daradka and 
Pollitt [2], using the proliferation marker bromohydroxiuridine (BrdU),  characterized the 
proliferative activity  of the hoof wall, describing it as a process exclusive to epidermal basal 
cells (EBCs) at the coronet, proximal lamellae, and terminal horn. However, the proliferation 
rates for coronary, terminal and sole tubular epidermis remain undetermined. Additionally, de 
Laat et al. [3] using TPX2, a nuclear protein expressed during the S, G2 and M phases of 
mitosis, detected increased proliferative rates in the EBCs of horses undergoing insulin-
induced laminitis suggesting that proliferative changes may play a role in the 
physiopathology. Thus the study of epidermal cellular proliferation of the lamellar tissue is of 
special significance.   
The main drawback of the currently utilized proliferation markers (BrdU and TPX2) for the 
determination of proliferation rates in the lamellar tissue is the complexity of the post-
processing steps required before detection of the actual markers. These steps normally 
include pre-treatment of the cells (DNA denaturation) and immunohistochemistry which are 
complex and time consuming techniques [4; 5]. 
The present study describes the use of the novel proliferation marker EdU (5-ethynil-2’-
deoxyuridine) for determining epidermal cellular proliferation in normal equine hooves. EdU, 
as with BrdU, is a thymidine analogue that is incorporated into DNA during the S phase of 
mitosis, thus labelling proliferating cells. The main advantage of EdU over its predecessors 
(BrdU and other proliferation markers) is the simplicity of the detection method in which a 
fluorescent dye is attached to the EdU molecule through a covalent bond making it detectable 
with simple fluorescence microscopy. This reaction takes only 30 min and does not require 
the use of antibodies, the denaturation of DNA or other complex steps.  
This study aims to evaluate EdU, administered locally to the foot of the horse using IV 
regional limb perfusion (RIVI).   Regional limb perfusion is well established for regional 
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delivery of antimicrobials to distal limb synovial structures, bone, and subcutaneous tissues 
[6-8] and has recently been established as an effective means of drug delivery to lamellar 
tissue [9]. The present study combines for the first time EdU labelling and RLP techniques, 
describing a new protocol for the study of cellular proliferation in the equine foot.  
 
4.3 Materials and Methods  
4.3.1 Animals 
Five Standardbred horses (four geldings and one mare, aged 3-25 years, weighing 380-515 
kg) with clinically normal feet were utilized for this study. The project was approved by the 
University of Queensland Animal Ethics Committee (approval number: SVS/338/11/UQ) that 
monitors compliance with the Animal Welfare Act (2001) and The Code of Practice for the 
care and use of animals for scientific purposes (current edition).  
 
4.3.2 EdU perfusions 
One of the fore limbs of every horse was randomly assigned to the treatment group and the 
contralateral limb to the control group. The instrumented digits were desensitized using a 
bilateral abaxial sesamoid nerve blocking applying 3 ml of Mepivacaine 0.2%
a
 per site of 
injection. Then, the digit was aseptically prepared and a tourniquet applied at the level of the 
fetlock. Thereafter, a 21G butterfly catheter was inserted into the lateral palmar digital vein 
and the treatment (EdU
b
 75mg dissolved in 35 ml of 0.9% saline solution) and control (35 ml 
of 0.9% saline solution) solutions were administered immediately to the respective limbs. The 
tourniquets were kept in place for sixty minutes and then the horses euthanized by I.V. 
sodium pentobarbitone (Lethabarb
c
) administration.  
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4.3.3 Sampling 
The forefeet were disarticulated at the fetlock joint. Ten tissue samples (15 x 10 x 5 mm) 
evenly spaced between the coronet and sole were collected from the midline section of the 
dorsal hoof wall of the treatment feet. Samples were labelled from TL1 (proximal) to TL10 
(distal). Control feet samples were taken only from proximal lamellae (CL1), mid-lamellae 
(CL5) and distal lamellae (CL10). Longitudinal tissue samples of coronet, periople, skin 
below and above the tourniquet as well as tongue were also harvested from both groups (Fig. 
4.1). 
 
4.3.4 Histological analysis 
Tissue blocks were fixed in formalin for 24 h and then kept in 70% ethanol until processed. 
The blocks were then embedded into paraffin blocks and trimmed, then 7 µm sections were 
cut and placed on standard microscope slides. The sections were de-waxed, rehydrated and 
processed for click chemistry (Alexa fluor 647 Click iT imaging kit
d
) according to the 
manufacturer’s instructions. Finally, cell nuclei were stained using Hoechst 33342e and 
sections cover-slipped using a water based mounting medium
f
. 
Fluorescence microscopy analysis was performed on a confocal microscope N1R
g
. Epidermal 
cells positive and negative to EdU were counted in 40 fields per section for the coronet 
(transverse (TS) and longitudinal sections (LS)), terminal papillae (TS), sole papillae (TS) 
and frontal sections. Cells were counted as well in the ten treatment lamellar sections (TL1-
TL10) in 4 PELs randomly selected in every section in 40 fields per section at 60X 
magnification using NIS Elements 10.0 software. The cells stained with both EdU and DAPI 
(red + blue fluorescence, respectively) were considered as positive cells, whilst those stained 
only with DAPI (blue) were considered negative. Using this information a proliferation index 
(PI%) was calculated  
 
4.3.5 Data analysis 
Simple Poisson models were used to quantify the association between positive cells count 
and tissue sections levels, accounting for the total number of cell counted in each section 
(used as an offset in the model). Because of the different nature of the sampled sections, three 
73 
 
models were used grouping the sections in: transverse lamellar sections (T1 to T10); 
coronary, sole and terminal tubular and intertubular hoof; and frontal sections (proximal and 
distal). All models were adjusted for clustering within horse and coefficient standard errors 
were generated using the cluster function in Stata 13
h
. 
 
4.4 Results 
EdU labelling in the foot was restricted to epidermal basal cells (EBCs) with occasional 
positive cells within the dermis. Positive cells were found in the skin and hair bulbs below the 
tourniquet. No EDU positive cells were identified in the skin above the tourniquet, the tongue 
or the control foot.  
Total number of epidermal cells, EdU positive epidermal cells and the derived PI% are 
summarized in Table 4.1. Proliferation was restricted to the coronary, terminal, and solar 
tubular and intertubular hoof and proximal lamellae. Proliferation at the coronet was 
significantly higher than in any other area sampled (p < 0.01) (Fig. 4.2). The PI% 
(mean±SEM) determined for LS coronary sections was 17.68 ± 1.23, whilst for the TS 
coronary section was 23.97±1.50. Differences between these sections were significant (p < 
0.01). Active proliferation was found in terminal tubular hoof (PI% = 9.58 ± 0.66) and solar 
tubular hoof (PI% = 6.02 ± 0.29), representing 32% and 15%, respectively (table 4.2), that of 
the coronet level (p < 0.01). Transverse sections of lamellae showed subjectively that there 
was consistent EBC proliferation located particularly at the axial tips of the primary 
epidermal lamellae (PELs) which appeared to diminish abaxially (Fig. 4.3A). The PI%± for 
the proximal lamellae (TL1) (4.01±0.54) was significantly higher than the other nine distal 
lamellar sections ( p < 0.01). The PI% decreased distally from TL2 (0.25± 0.09), being 
almost non-existent in the middle and distal lamellae (PI% at TL10= 0.07 ± 0.01) (Fig. 4.4). 
 
4.5 Discussion 
The administration of EdU via RIVI resulted in successful labelling of proliferating 
epidermal basal cells in the equine hoof. Previous studies used  EdU to assess  in vitro cell 
cultures [10; 11] chick embryos [12] or live mice utilizing an intra-peritoneal approach [4; 5]. 
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This is the first study describing the administration of EdU intravenously to horses. The 
regional delivery of the marker via (RIVI) to a single foot allowed use of a reduced total 
dose, cost and exposure to possible toxic effects. No EdU positive cells were found in the 
skin above the tourniquet, tongue or contralateral foot. This showed a tourniquet at the level 
of the fetlock for 60 minutes, in the static standing horse, effectively restricted the 
distribution of the EdU to just the foot thus avoiding wastage into the systemic circulation. 
Cells positive to EdU were found in in the bulb and outer sheath of hair and in the stratum 
basale and spinosus of skin sampled below the tourniquet (Fig. 4.5). The distribution of 
proliferating positive cells in hair and skin, after 60 min of exposure to EdU, was similar  to 
that described in previous studies using BrdU in ponies [2] and sheep [13] for the same 
period of time, however no PI have been previously calculated for equine hair and skin.  
Sectioning of the tissue is an important factor for the correct determination of the 
proliferative index (PI%) at different levels of the hoof wall. As an example, the highest 
number of proliferating cells was in the epidermis of the coronary inter-tubular and tubular 
hoof. The distribution of positive cells in tubular horn varied and most were located 
proximally diminishing distally down the walls of the tubule. Thus, PI% for the LS section 
was derived from both high and low PI zones and was 17.68(±1.23) whilst TS sections 
reached 23.97(±1.50).  These TS sections were through the proximal high PI zone and 
skewed the result  
Daradka and Pollitt [2] previously described the presence of proliferating cells at the 
coronary and terminal epidermis using BrdU; however this is the first time a PI% has been  
calculated for sole papillae (PI%=6.02(±0.29)). Lamellar proliferative activity was studied at 
ten different levels (TL1 to TL10). The highest PI% was found proximally at TL1 and 
decreased from TL2 to TL10, similar to previous descriptions [2]. Frontal sections of the 
proximal and distal lamellae confirmed this proliferation pattern showing the majority of 
positive EBCs at the most proximal region of the lamellae decreasing to be almost non-
existent distally (Fig. 4.6A and 4.6B). 
The distribution of these proliferating cells along the primary epidermal lamellae was 
especially interesting. After 60 minutes of exposure to EdU the majority of positive cells 
were found only at the axial side of the PELs extending from their tips to the beginning of the 
keratinized axis of the PELs. The proliferative potential, origin and fate of cells located in the 
abaxial side of the PELs deserve further research. The analysis of LS sections containing 
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coronary papillae and proximal lamellae evidenced a continuum of EBC proliferation from 
coronary horn to the proximal lamellae. The absence of proliferation in the middle and distal 
lamellae confirms that the main cellular proliferation activity in the hoof wall is provided by 
the coronet and proximal lamellae, whilst terminal papillae and sole papillae contribute to the 
proliferation of the distal structures (linea alba and sole). The cells located in the distal 
keratinised axis of PELs are derived  from proximal areas where proliferation actively occurs. 
Proliferation at other levels of the lamellae appears to be occasional or rare, minimally 
contributing to the growth of the hoof wall. 
Based on the present results, the  concept of a “sterile bed” proposed by Leach and Oliphant 
[14] does not apply  to all  areas of the lamellar tissue. It does apply to the middle and distal 
lamellae (TL2 to TL10), where minimal proliferation occurs. The mechanisms that allow 
displacement of the EBCs distally whilst they maintain their attachments to the underlying 
basement membrane and to surrounding cells is still unresolved. For a better understanding of 
these processes further investigation should be focused on the cellular cytoskeleton and 
junctional components and their interactions during the growth and remodelling process of 
the hoof wall.  
Although the distribution of EdU positive cells appears to be equivalent to that observed 
previously using systemically administered BrdU, PI%s here calculated were consistently 
lower than that of Daradka and Pollitt [2]. Several factors related to the technique such as: 
administered marker concentration, time of exposure of the tissue to marker, mechanism of 
detection and cell counting protocol may have influenced the PI% in this study. A direct 
concentration effect has been previously described for the fluorescent activity of EdU [10; 
15]. In vivo experiments assessed increasing concentrations of the marker delivered via 
intraperitoneal injection to rats [5]. The EdU concentration evidencing the highest fluorescent 
activity was 50mg/kg. Estimating the equine foot weight at approximately 1.5kg, a total dose 
of 75mg was here selected. Higher and lower concentrations of EdU should be assessed in 
order to determine the best fluorescent response of the EBCs in the lamellae. Time exposure 
is a considerable factor when comparing the PI% between systemic and regional delivery 
models (RIVI). Daradka and Pollitt [2] administered BrdU (35mg/kg) systemically to 5 
ponies harvesting the lamellar tissue after 60 min. Although in the present study horses’ feet 
were exposed to the proliferation marker for the same period of time, the total EdU dose to 
the feet may have differed:  BrdU was administered intravenously and diluted  in the 
systemic circulation but recirculation of the marker to the lamellae may have enhanced 
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delivery of BrdU to the cells. In the RIVI model restricted blood circulation caused by the 
tourniquet may have affected the distribution of the marker within the tissue and 
compromised uptake by the EBCs.  
The mechanism of detection is one of the main advantages of EdU. Unlike BrdU, EdU does 
not require the use of complex DNA denaturation or immunohistochemistry techniques for 
the development process. This avoids damage to other antigens and tissue disruption making 
EdU labelling easy to combine with other immunofluorescence techniques [5; 10; 15]. To 
make the EdU molecules fluoresce, only a simple and rapid click chemistry reaction is 
required, forming a very specific covalent bond with the fluorescent azide probe [5].  
Additionally, the molecules involved in the click chemistry reaction are 1/500
th
 the size of the 
antibodies needed for BrdU [11], thus they can effectively diffuse within the tissues and into 
the double-stranded DNA. Lastly, differences in the PI% between the two studies could be 
accounted for by the number of cells counted: the total number of cells counted in the present 
study was considerably higher than those analysed previously by Daradka and Pollitt [2]. 
Although this fact may increase the sensitivity of this study, comparisons between both 
methods may not be representative. The use of different counting protocols may cause 
considerable variations in the PI% calculated. As an example, the present study demonstrated 
that in the proximal TS sections of the lamellae, cell proliferation was concentrated at the tip 
of the PELs diminishing toward their base. Considering the number of counted cells at the 
same level in previous studies and the lack of detail in the counting protocol used [2], the 
inclusion of these areas with lower proliferation rate in the PI% calculation cannot be 
assured, possibly skewing the results.  
The sensitivity of EdU versus BrdU was previously compared in vitro using breast cancer cell 
cultures [10], neurospheres derived from human olfactory mucosa [5] and in vivo using 
pregnant mice [5]. No substantial differences were observed between the two methods, 
indicationg that the sensitivity of EdU is equivalent to that of BrdU. Additionally it has been 
previously reported that EdU has a lower cytotoxicity than BrdU making it  a better candidate 
for in vivo experimentation [15].Validation of the present protocol should be performed 
against BrdU to determine if the presence of the tourniquet and/or different EdU doses played 
a significant role in the detection of proliferating cells in the lamellar tissue. As EdU can be 
delivered via RIVI to a single foot, both protocols could be assessed simultaneously in the 
same horse.  
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EdU labelling appears to be a viable alternative technique to detect proliferating cells in vivo 
in the hoof wall. Although this technique can be potentially applied to virtually any tissue, the 
present protocol might be of particular use for the study of cellular proliferation in laminitis, 
including insulin mediated models  where EBC proliferation has been implicated [3; 16; 17]  
and in chronic laminitis cases where the development of a proliferating epidermal lamellar 
wedge contributes to distal phalanx pathology and complicates rehabilitation [18]; a better 
understanding of the dynamics and temporal development of the wedge will inform improved 
control and therapy.   
Due to the simplicity of the presented protocol, the EdU labelling technique would be 
suitable for field research situations and also could easily be used to study clinical cases 
subjected to euthanasia, contributing to the understanding of the pathologic process of 
naturally occurring laminitic cases.  
 
4.6 Conclusion  
EdU labelling is a simple technique for the study of cellular proliferation in the equine hoof. 
The novel protocol here described using regional delivery (RIVI) allowed the reduction of the 
total dose administered, reasonable cost and decreased exposure to possible toxic effects.  
Cellular proliferation was restricted to specific zones of the hoof wall. The coronet and 
proximal lamellae showed the highest cellular proliferation rates contributing to the 
formation of the stratum medium and internum of the hoof wall respectively. Lower but 
considerable proliferation rates were observed at the terminal and sole horn whilst the middle 
and distal lamellae show negligible proliferative activity.  
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4.7 Manufacturers 
a
 Nature Vet, Glenorie, NSW, Australia  
b, d, e 
Innvitrogen, LifeTechnologies, Carlsbad, CA, United States of America  
c
 Virbac Animal Health, Milperrin, NSW, Australia  
f
 Dako, North Sydney, NSW, Australia 
g
 Nikon, Konan, Minato-ku, Tokyo, Japan 
h
 StataCorp LP, Texas, USA. 
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Table 4.1: Summary statistics of mean±SEM of the total number of epidermal cells (TNC), 
total number of positive epidermal cells (TNPC) and proliferation index (PI%) determined in 
16 different areas of treatment hooves.  
Key: ±SEM standard error of the mean 
  
Level TNC (±SEM) TNPC (±SEM) PI% (±SEM) 
L1 6675.40 (±1423.00) 233.00 (±32.18) 4.01 (±0.54) 
L2 7056.80 (±1295.00) 15.80 (±5.89) 0.25 (±0.09) 
L3 7967.40 (±1512.00) 8.20 (±2.40) 0.09 (±0.02) 
L4 7449.60 (±1065.00) 5.80 (±1.07) 0.08 (±0.02) 
L5 8561.20 (±945.60) 13.60 (±3.06) 0.16 (±0.02) 
L6 9597.40 (±918.70) 11.40 (±1.54) 0.12 (±0.02) 
L7 8228.20 (±469.40) 7.20 (±1.80) 0.09 (±0.02) 
L8 8931.60 (±551.30) 9.40 (±2.54) 0.11 (±0.03) 
L9 9607.00 (±794.60) 5.80 (±1.20) 0.06 (±0.01) 
L10 7688.60 (±1088.00) 5.80 (±1.66) 0.07 (±0.01) 
LS coronary tubular 
hoof 
4981.40 (±2243.00) 831.40 (±339.80) 17.68 (±1.23) 
TS coronary tubular 
hoof 
717.40 (±43.33) 171.20 (±12.47) 23.97 (±1.50) 
Sole tubular hoof 1319.20 (±69.06) 79.00 (±4.31) 6.02 (±0.29) 
Terminal tubular 
hoof 
2115.60 (241.20) 197.40 (±15.14) 9.58 (±0.66) 
Frontal proximal 2632.00(±217.8) 164.80 (±52.61) 5.86 (±1.88) 
Frontal distal 2146.80 (±577.70) 7.60 (±5.90) 0.39 (±0.33) 
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Table 4.2: Regression coefficients from a simple Poisson model, comparing EdU positive 
cells counted in 16 different sections of lamellar tissue of treated horses (n = 8).  
Lamellar area Mean count 
ratio 
95% CI P value 
L1 Reference - - 
L2 0.07 0.03 – 0.14 < 0.01 
L3 0.03 0.02 – 0.05 < 0.01 
L4 0.02 0.02 – 0.03 < 0.01 
L5 0.05 0.03 – 0.08 < 0.01 
L6 0.04 0.03 – 0.06 < 0.01 
L7 0.03 0.02 – 0.04 < 0.01 
L8 0.03 0.02 – 0.06 < 0.01 
L9 0.02 0.01 – 0.03 < 0.01 
L10 0.02 0.01 – 0.04 < 0.01 
    
LS coronary tubular 
hoof 
Reference - - 
TS coronary tubular 
hoof 
0.44 0.29 – 0.68 < 0.01 
Sole tubular hoof 0.15 0.9 – 0.26 < 0.01 
Terminal tubular 
hoof 
0.32 0.19 – 0.52 < 0.01 
    
Frontal proximal Reference - - 
Frontal distal 0.05 0.01 – 0.31 < 0.01 
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Figure 4.1: Diagram of the hoof’s 
inner structures, showing the 
different sectioning planes for the 
acquisition of tissue samples.The 
orientation of the different planes 
are: A, longitudinal sections (LS) 
B, frontal sections and C, 
transverse sections (TS). 
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Figure 4.2: Photomicrograph showing the normal proliferative activity in a longitudinal (LS) 
section of the coronary tubular and intertubular epidermis. A’ is a magnification of the box in 
A. Nuclei were stained with Hoechst 3342 (DAPI, blue) and proliferating cells labelled with 
EdU and detected with Alexa fluor 647 Click iT imaging kit (Cy5, red). Proliferation is 
concentrated in the proximal aspect of the tubular hoof (box) diminishing distally.  
  
A A’ 
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Figure 4.3: Photomicrograph demonstrating the normal proliferative activity in the proximal 
lamellae (A: transverse section (TS) of area L1) and coronary tubular epidermis TS (B). A’ 
and B’ are magnifications of respective boxes. Nuclei were stained with Hoechst 3342 
(DAPI, blue) and proliferating cells labelled with EdU and detected with Alexa fluor 647 
Click iT imaging kit (Cy5, red).  
  
A 
 
 
 
B B’ 
A A’ 
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Figure 4.4: Photomicrograph showing the normal epidermal cellular proliferation at the mid-
lamellae (TL5). A’ is the magnification of the respective boxe. Nuclei were stained with 
Hoechst 3342 (DAPI, blue) and proliferating cells labelled with EdU and detected with Alexa 
fluor 647 Click iT imaging kit (Cy5, red). Proliferation at this level is rare or occasional 
compared to the proximal levels of the lamellar tissue.  
  
  
A A’ 
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Figure 4.5: Photomicrograph of skin below the tourniquet (A) and a hair follicle from skin 
below the tourniquet (B). Nuclei were stained with Hoechst 3342 (DAPI, blue) and 
proliferating cells labelled with EdU and detected with Alexa fluor 647 Click iT imaging kit 
(Cy5, red). Active cellular proliferation was observed in stratum basale and spinosus of the 
skin below the tourniquet (A). The majority of proliferating cells in the the hair of skin below 
the tourniquet were located in the bulb area (B).  
  
A B 
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A’ A 
B B’ 
Figure 4.6: Photomicrograph 
of proximal (A) and distal (B) 
frontal lamellae sections.A’ 
and B’ are magnification of 
respective boxes. Nuclei were 
stained with Hoechst 3342 
(DAPI, blue) and 
proliferating cells labelled 
with EdU and detected with 
Alexa fluor 647 Click iT 
imaging kit (Cy5, red). Active 
cellular proliferation was 
detected at the proximal area 
of the lamellar tissue (A’). 
Positive cells were not 
observed distally in the mid 
lamellar area (arrows head). 
The presence of proliferating 
cells was rare or occasional in 
the distal lamellae (B’). 
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Part III: Conclusion 
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Chapter 5: General Discussion 
 
The first part (Chapter 2) of the study presented in this thesis describes the local effects of 
exogenous insulin on cellular proliferation and histomorphometry. The second part (Chapter 
3) reports the effects of insulin on equine lamellar perfusion and cellular glucose metabolism. 
This study is the first to use tissue microdialysis to deliver insulin to the hoof lamellae. This 
particular model was used because it allowed the researcher to monitor the local effect of a 
high concentration of insulin delivered into the lamellae in real time in the standing horse.  
Several factors were considered when selecting an appropriate concentration of insulin for the 
perfusion. These included: plasma insulin concentrations achieve in previous studies  for the 
induction of laminitis (Asplin et al., 2007) (de Laat et al., 2010a); the insulin concentrations 
that elicited a physiological effect in previous microdialysis studies of rat brains (McNay et 
al., 2013) and human muscle (Rosdahl et al., 2000);  the stability of insulin in highly diluted 
solutions (Blackshear et al., 1983; James et al., 1981; Stickelmeyer et al., 2000); previous 
evidence of insulin loss in microdialysis systems (Jansson et al., 1993); and in vitro 
determinations performed in our laboratory (Appendix 1). Thus, a concentration of 100 µg/ml 
of insulin was chosen for the tissue microdialysis perfusate.  This delivered adequate insulin 
to the lamellar tissue to test our hypotheses.  Although insulin concentrations in the lamellar 
tissue of normal or laminitic horses remain undetermined, studies have demonstrated that the 
insulin concentration in other tissues, including skeletal muscle and adipose tissue, are 
approximately 50% of circulating concentrations (Jansson et al., 1993; Sjostrand et al., 1999). 
The estimated concentration delivered into the lamellar tissue in the current studies (0.5 
µg/ml) was approximately 14 times greater than the systemic concentration of insulin reached 
by Asplin et al. (2007)  and  de Laat et al. (2010a) during the experiments performed on 
ponies and horses using a prolongued euglycemic hyperinsulinemic clamp (p-EHC). 
Considering that insulin dynamics in the lamellae are unknown and that the single source 
point of insulin delivery in our studies was the microdialysis probe, our aim was to deliver a 
higher concentration of insulin in order to ensure at least a similar biological effect to that 
previously observed in the systemic insulin-induced model using a p-EHC. 
The local delivery of insulin for 24 h affected lamellar histomorphometry and cellular 
proliferation. In Chapter 2, significant differences (p < 0.05) in PELL and NKPEL were 
observed between treated and control groups. The combination of longer PELL with 
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conserved KPELL, found exclusively at area L1 (surrounding the microdialysis probe), 
supports a direct effect of insulin on tissue organization, particularly affecting SELs at the tip 
of the PELs closest to the microdialysis probe.  
Histomorphometric changes have been described previously by Asplin et al. (2010a) and de 
Laat et al. (2013a) during the induction of laminitis using a pEHC. Elongation and narrowing 
of the SELs, with minimal compromise of the basement membrane, were the main features of 
the systemic, insulin-induced laminitis model. Tissue disorganisation was proposed as the 
probable cause of the weakening of the lamellae, compromising the dermo-epidermal 
junction (de Laat et al., 2013a; de Laat et al., 2013c). Increased EBC mitotic activity and a 
concomitant increased number of cells was suggested as the main causes for SEL lengthening 
after 48 h of exposure to extreme hyperinsulinemia. Using a similar p-EHC technique, 
Karikoski et al. (2014b) confirmed lengthening of the PELs after exposure of horses to 
hyperinsulinemia. A combination of more proliferating cells and more apoptotic cells was 
identified suggesting an accelerated cell apoptotic-proliferation process, with no net change 
in the total cell number. However cell stretching was suggested as the most likely cause of 
the lengthening of the PELs rather than increased proliferative activity. 
A novel protocol for labelling proliferating EBCs within the lamellar tissue is described in 
Chapter 4. For the first time, the proliferation marker EdU was administered to the foot of the 
horse intravenously, using a regional delivery technique. EdU is an analogue of the 
nucleotide thymidine. It is incorporated in the DNA during the synthesis stage of mitosis, and 
is detected in fixed samples through a click chemistry reaction. The detection process takes 
30 min and this is one of the main advantages over its predecessor BrdU, which required 
DNA denaturation and immunohistochemistry during the developing process. Also, the 
reagent used during click chemistry is 1/500th the size of the antibodies needed for BrdU 
(Salic and Mitchison, 2008), penetrating easily into the sampled tissue and DNA without 
requiring denaturation. 
The EdU labelling technique successfully labelled proliferating EBCs in the equine hoof 
wall. The results are consistent with previous findings by Daradka and Pollitt (2004b), 
confirming that the main cellular proliferation activity in the hoof wall is provided by the 
coronet and proximal lamellae, whilst terminal papillae and sole papillae contribute to the 
proliferation of the distal structures (linea alba and sole). Proliferation at other levels of the 
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lamellae appears to be occasional or rare, contributing minimally to the growth of the hoof 
wall. 
Although this new technique could be applied to virtually any tissue for the study of cellular 
proliferation, the present protocol will be of special interest for the study of cellular 
proliferation in the equine foot and its implications for laminitis models.   
In Chapter 2, the EdU labelling technique was used for the study of the cellular proliferation 
after 24 h of exposure of the lamellae to exogenous insulin in vivo. The mean number of 
TNPC detected in the treatment group was 42 times that of the control, with a clear trend 
toward statistical significance (p=0.07), with sections closest to the microdialysis membrane 
(L1) having the highest proliferation activity. Considering that no differences were found in 
the total number of cells between treated and control limbs in the present study, the 
lengthening detected by increased PELL and NKPEL could not be explained by an increase 
in proliferative activity as was initially suggested by de Laat et al. (2013a). Therefore, the 
data support cellular stretching as the cause behind insulin disrupting lamellar architecture 
when delivered locally. 
The proliferation rate of EBCs located in the mid-lamellar region of normal horses is 
generally negligible (Daradka and Pollitt, 2004a). This corresponds to the area where the 
microdialysis probes were placed. Control feet showed similar proliferation rates to those 
described in Chapter 4 for areas sampled at the same level. This demonstrates that the 
insertion or presence of the microdialysis catheter, or other factors, did not increase EBC 
proliferation in the lamellar tissue of control horses. Thus, the results support increased 
proliferation in the treated feet as the likely direct effect of insulin. 
Several secondary reactions are triggered once insulin binds to its receptors (InsR or IGF-
1R). Insulin modulates glucose metabolism, cell growth, cellular differentiation and 
cytoskeletal organization (al-Habori, 1993; Berfield et al., 1996; Berfield et al., 1997). The 
last of these may be of special interest for the understanding of insulin-induced laminitis. The 
cytoskeleton is a complex network of protein fibres responsible for spatial organization of the 
cell, cell shape and mechanical resistance to deformation. Additionally, the cytoskeleton is 
involved in the modulation of other cellular functions such as cell signalling pathways, 
intracellular transport and cellular division, among others (Schulingkamp et al., 2000b). 
Previous studies using cultured rat mesangial cells demonstrated the rearrangement of the 
filamentous polymer of actin (F-actin) from normal patterns to a parallel central aggregated 
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distribution after exposure to insulin for 1 h. The researchers observed severing of peripheral 
adhesion points losing the attachment to the nuclei and other organelles, similar to what 
occurs in cells preparing to move or divide (Berfield et al., 1996). Conversely, the exposure 
of rat glomerural mesangial cells to insulin-like growth factor I (IGF-I) produced a different 
response. Cells suffered a progressive elongation, resulting in an extremely stretched bipolar 
cell (Berfield et al., 1997).  A similar process may occur in the lamellae. Research conducted 
by Burns et al. (2012b) demonstrated that the InsR distribution within the equine hoof was 
restricted to the lamellar vasculature, whilst IGF-1R were ubiquitous. The main ligand for 
IGF-1R is IGF, however, in exceptional conditions when insulin concentrations are 
supraphysiological insulin can bind IGF-1R producing an IGF-like effect. Thus, the increased 
PELL and NKPEL observed in Chapter 2 may be explained by a direct effect of insulin on 
the cytoskeletal organization of the EBCs, via the IGF-1R. The histomorphometric changes 
reported are consistent with the previous histological description by de Laat et al. (2013a). 
This supports the idea of insulin modifying the EBCs’ cytoskeleton, and is also compatible 
with the loss of the normal histological organization of the lamellar tissue as both de Laat et 
al. (2013a) and Karikoski et al. (2014b) previously stated.  
The occasional compromise of the basement membrane (BM) was one of the characteristics 
of the insulin-induced model observed by de Laat et al. (2013a). The BM is fundamental for 
anchoring the parietal surface of the distal phalanx to the cytoskeleton of the EBCs. 
Hemidesmosomes are the adhesion point between extracellular collagen fibres and the keratin 
(intermediate filament) cytoskeletal fibres. Cross-talk between insulin and integrins (one of 
the main proteins constituting the structure of hemidesmosomes) has been identified 
(Guilherme et al., 1998). Integrins are heterodimer transmembrane receptors that mediate 
interactions between the cell surface and the extracellular matrix and also initiate signalling 
events including tyrosine phosphorylation, cytoskeletal reorganization (Burridge et al., 1992; 
Dedhar and Hannigan, 1996; Schwartz et al., 1995), initiation of mitogen-activated protein 
kinase (MAPK) cascades, and the modulation of cellular metabolism (Chen et al., 1994). 
Leipzig et al. (2006) found that IGF-1R collaborate with integrins to regulate focal adhesion 
proteins, and are also associated with the MAPK signalling pathway. Additionally, an 
increased amount of F-actin was found in bovine chondrocytes that were treated with IGF-1, 
causing cellular stiffness and adhesion to the extracellular matrix. The capability of insulin to 
increase cellular adhesion to extracellular matrix components may explain why BM 
detachment was minimal in the reports of  Asplin et al. (2010a) and de Laat et al. (2011). 
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Previously, weight bearing was suggested as a possible triggering or contributing factor to the 
disruption of the dermo-epidermal junction during laminitis. This statement was based on the 
differences in the level of BM damage present in the lamellar tissue of ponies vs. horses 
during the systemic insulin-induced model (Asplin et al., 2010a; de Laat et al., 2013a). In the 
local model presented in this thesis, weight bearing exerted normal tension along all parts of 
the lamellar tissue. Since the area perfused by the microdialysis membrane was minimal in 
relation to the total hoof wall surface, mechanical distractions due to increased tension as a 
consequence of the failure of the SADP were assumed absent However, BM detachment was 
observed in 30% of the treated sections, varying from grade 1 to 3. Isolated BM separation in 
control sections was also observed (12.5%), but never exceeding grade 1. The median 
laminitis histology score for L1 sections in the treatment group was 1 (mild), whilst for all the 
remaining sections in both groups it was 0 (normal). This difference showed a  trend toward 
significance (p = 0.062), and in conjunction with the histomorphometric changes reported, 
the present work supports the hypothesis of insulin itself affecting the lamellae tissue 
organization and compromising the BM integrity, as de Laat et al. (2013a) previously 
reported. 
In Chapter 3 the effects of local delivery of insulin on lamellar cellular metabolism and 
perfusion were studied. Although no significative differences were found in the metabolites 
concentrations between groups, the AUC of glucose concentrations were lower in five of the 
six treated horses during the period from 9 to 24 h, with no changes in lamellar perfusion. 
Glucose is essential to maintain attachment between the dermal and epidermal layers and it is 
stated that the equine foot consumes more glucose than the head (Wattle and Pollitt, 2010). 
Previous research by Pass et al. (1998) demonstrated that lamellar tissue explants deprived of 
glucose are unable to maintain the dermo-epidermal junction, demonstrating that glucose 
supply is fundamental for the normal function of the lamellar tissue. As glucose cannot be 
stored within the hoof (Wattle and Pollitt, 2004) , the amount of glucose reaching the 
lamellae relies on the local perfusion rate. Therefore, the apparent lower concentrations of 
glucose observed in the treated group might be a consequence of the effects of insulin either 
reducing the local blood flow to the lamellae, or the result of a higher uptake and metabolism 
by the EBCs. In this experiment, lamellar perfusion was assessed via tissue microdialysis and 
urea clearance with no changes in blood flow after 24 h of exposure to insulin. Although  
lamellar perfusion is  influenced by limb load cycling , urea clearance appears to be sensitive 
technique to assess vascular changes in the lamellar vasculature in the static, standing horse, 
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as described by Medina-Torres et al. (2014a). The present results do not support changes in 
lamellar perfusion as a direct consequence of insulin stimulus, and differ from previous 
results presented by de Laat et al. (2012b) in which increased hoof wall surface temperature 
(HWST), presumably due to vasodilation, was observed during the developmental stage of 
insulin-induced laminitis. However, HWST can be influenced, not only by changes in 
perfusion, but also by ambient temperature and metabolic activity of the submural tissue 
(Hood et al., 2001). Therefore, it is possible that the observed increases in HWST in previous 
studies using the p-EHC (de Laat et al., 2012b) were due to increases in metabolic rate, rather 
than vasodilation.  In the current studies, in the absence of changes in urea clearance, the 
most likely cause for decreased dialysate glucose concentrations in the treated group was 
increased glucose uptake by the EBCs, possibly driven by increased metabolic rate, indirectly 
mediated by insulin.  
Asplin (2009) previously studied lamellar glucose metabolism and its implications for 
laminitis. Their work demonstrated that EBCs regulate glucose uptake in an insulin-
independent manner, mainly through the transmembrane glucose transporter protein GLUT-1 
(Asplin et al., 2011). However, as previously discussed above, the insulin-IGF-1R binding is 
capable of activating several signalling pathways modulating cellular proliferation and 
cellular metabolism (Agathocleous and Harris, 2013). The pathways PI3K, AKT and mTOR 
for example, modulate glucose uptake, glycolysis, fatty acid, protein and nucleotide 
synthesis, and also interact with each other to coordinate cellular state and metabolism 
(Agathocleous and Harris, 2013). It has been described that tumours and cells undergoing 
active proliferation experience a metabolic shift requiring substantially higher amounts of 
energy in comparison to normal tissues (Fritz and Fajas, 2010; Grabellus et al., 2012). This 
might be the reason why EBCs respond to the effects of insulin by cytoskeleton disruption 
and the diverse secondary pathways that can be activated, changing the metabolic 
requirements of lamellar tissue. Increased metabolic activity is usually an exothermic process 
(Hood et al., 2001). Future local or systemic insulin delivery models should be performed 
under temperature-controlled conditions, combining HWST monitoring, energy metabolite 
and urea clearance in order to confirm this hypothesis. 
The limitations of the present work include the microdialysis probe placement protocol, the 
position of the membrane in relation to the distal phalanx and EBCs, insulin tissue dynamics 
and the size of the data set. Variability in the location of the microdialysis probes placed in 
the lamellar tissue was a consequence of the lack of precision in the needle insertion 
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technique. Individual anatomic differences of the horses’ hooves and the angle of insertion, 
which is approximated using the hoof wall surface as a reference, result in slightly different 
positioning of the microdialysis probes. The proximity of the membrane to the EBCs or to the 
bone surface is likely to have influence the actual sampled/perfused area. Metabolite 
concentrations may fluctuate due to a metabolic gradient between dermis and epidermis. The 
amount of insulin reaching the EBCs and their response to the insulin stimulus could have 
been affected by the distance between the microdialysis probe and the tissue. The correlations 
observed in the treatment group between the concentrations of glucose and L:G, and the 
distance from the probe to the closest 5 PELs to the membrane, support the idea that insulin 
effects are affected by the distance from the microdialysis probe to the EBCs and, therefore, 
the insulin concentration reaching the epidermis. The closeness of the membrane to the 
dermal vasculature must be also considered. Wang et al. (2006a) described the transport of 
the insulin molecule from vasculature to skeletal muscle in dogs, demonstrating that the InsR 
is required by the endothelial cells to transport insulin from the blood stream to the tissues. 
The lamellar dermis is highly vascularized and the lamellar capillaries express the InsR 
which might result in the removal of the insulin molecule from the tissue, possibly affecting 
the insulin diffusion and distribution in the lamellar tissue. Additionally, insulin effects may 
be time and/or concentration-dependent. In the systemic insulin-induced model (de Laat et 
al., 2010a) histomorphological changes were evidenced early in disease progression (6 h), 
whilst in previous proliferation studies in vitro (Bailey and Chockalingham, 2010) insulin 
took up to 48 h to exerts a detectable effect on cell proliferation. Considering the small area 
perfused here and the unknown behaviour of insulin in the lamellar tissue, longer times of 
exposure and also different insulin concentrations might cause different or more advanced 
effects. A bigger data set should be considered in future research to increase statistical power 
and significance.  
The histomorphometric changes observed here support a direct effect of insulin on lamellar 
tissue, whilst the metabolic effects of insulin warrant further research. As the EBCs lack 
InsR, an interaction between insulin and IGF-1R is suggested, possibly compromising 
epidermal cellular metabolism and the EBC cytoskeleton. Future research should be focused 
on the study of the cellular components of the EBCs in conjunction with local or systemic 
insulin delivery models. Particular attention should be paid to desmosome and 
hemidesmosome integrity and stability during laminitis induction. The interaction between 
insulin and cytoskeletal components may be understood through analysing the lamellar tissue 
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using electron microscopy. Insulin determinations should be performed in the lamellar tissue 
of normal and laminitic horses. Understanding how insulin is transported from the systemic 
circulation to the EBCs and vice versa, as well as the actual insulin tissue concentrations 
triggering laminitis, is important to comprehend insulin effects on the lamellae and to be able 
to replicate the disease in experimental models in a better and more realistic way. 
Although tissue microdialysis appears to be a good alternative for the delivery of insulin to 
the lamellae, new possibilities should be assessed. Using the same insertion protocol 
described here, tissue microdialysis probes may be replaced or used in combination with 
insulin infusion sets similar to those utilized in human insulin pump therapy. This would 
allow precise control over the concentration of insulin delivered to the tissue. However, it 
would necessitate the addition of extra fluid volume to the interstitium and is, therefore, 
perhaps a less physiologic delivery method than microdialysis. The use of this technique and 
tissue microdialysis together, in two different areas of the same hoof, could be used for the 
study of insulin transport and diffusion in the lamellar tissue.  
Finally, the study of the InsR and IGF-1R deserve further investigation. The actual role of 
IGF-1R in the pathophysiology of laminitis remains unclear. However, based on the current 
results and previous evidence, IGF-1R appears to be fundamental in the interactions between 
insulin and the EBCs. 
 
5.1 Conclusion 
Ttissue microdialysis appears to be suitable for local insulin delivery to the lamellar tissue 
and may be useful as a model for future studies of the direct effects of insulin on lamellar 
tissue. However, further work is required in order to determine the local tissue concentrations 
of insulin achieved with the technique. The present work supports insulin as the main 
component responsible for the changes in lamellar architecture observed and supports the 
hypotheses of Asplin et al. (2007)  and de Laat et al. (2010a), that insulin itself is a triggering 
factor for laminitis. 
An interaction between insulin, IGF-1R, cellular metabolism and EBCs’ cytoskeleton is 
suggested, according to the lengthening of the PELs and increased proliferative activity 
described. Bioenergetic failure and ischemia (or hyperaemia) were consequences not 
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observed during local-delivery of exogenous insulin. The apparent decreased interstitial 
glucose concentrations, without a detectable change in perfusion (urea clearance), do not 
support direct vascular effects of insulin on the lamellae, and suggest an increased rate of 
cellular glucose uptake, possibly secondary to a metabolic shift of the EBCs resulting in 
increased metabolic rate: however, more research should be carried out to confirm the effects 
of insulin on the EBCs metabolism.  
Further research should be focused on the interactions between insulin, its receptors (InsR 
and IGF-1R), the secondary signalling pathways and the cytoskeleton. The inspection of the 
cytoskeletal components, BM and adhesion protein under electron microscopy may aid to 
understand the actual effects of insulin at a cellular level. 
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Appendix 1: Preliminary assessment of microdialysis insulin 
delivery in vitro  
 
A.1 Preliminary assessment of microdialysis insulin delivery in vitro  
A considerable amount of insulin adsorption can occur within a microdialysis system 
(Jansson et al., 1993), therefore an in vitro calibration was performed to estimate the actual 
amount of insulin delivered by the microdialysis system used in the current study.  
A.1.1 Microdialysis in vitro 
Microdialysis probes (CMA20
a
, 0.5 mm, 10 mm long, 100 kDa cut-off membrane) 
were placed into a 1.5 ml low protein binding polypropylene vial (Lo-bind
b
) containing 1 ml 
of HPLC grade water
c
. The probe inlet was connected to a microdialysis pump (801 Syringe 
pump
d
) and the outlet placed into a 0.5 ml polyproplylene vial (Lo-bind
b
).  Based on previous 
studies (McNay et al., 2013; Rosdahl et al., 2000) five insulin preparations (2, 17, 100 and 
348 µg/ml) were created by diluting respective amounts of recombinant human insulin 
(Actrapid
g)
 in a commercial polyionic microdialysis perfusion fluid (T1
a
). Each preparation 
was loaded in a 1 ml syringe
e
 and perfused at 1 µL/min for 4 hours, with experiments 
performed in triplicate. Insulin concentrations were determined in the solution outside the 
membrane, dialysate and prepared syringe. 
  
A.1.2 Chromatography and mass spectrometric conditions 
 Analyses were performed on a Shimadzu LCMS-8030 triple quadruple mass 
spectrometer coupled to Nexera UHPLC system. Chromatographic separation was made 
using a reverse phase C18 column (Kinetex, 1.7 µm  XB-C18, 100A, 50 x 2.1 mm, 
Phenomenex) column at a temperature of 40˚ C. The mobile phases consisted of UPLC-grade 
water with 0.1% formic acid (phase A) and 100% acetronile with 0.1% formic acid (phase B). 
Total acquisition time was 1 min and total flow was 0.2 µl/min, isocratic 70% B. Mass 
spectrometry parameters were optimized manually with Labsolutions ver. 5 (Table AP-1). 
Detection was accomplished using ionized recombinant human insulin (Actrapid) [5803.75 + 
5H
-
]
5+
 precursor 11.61.75 m/z and product 226.15 m/z. Dwell time was set at 10 msec and 
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collision energy at -69 V. Calibration and quality control samples were prepared dissolving 
measured obtained by spiking the blank matrix with known amounts of insulin. The 
calibration curve (0.01 to 100 µg/ml) was analysed using linear regression with a minimum 
R
2
 of 0.99. 
A.2 Results  
 The insulin concentrations determined for the solution outside the membrane, 
dialysates and prepared syringe are summarized in the Table AP-2. The mean (range) insulin 
recovery (concentrations around the microdialysis membrane) was 0.5 (0.14 – 1.1) %, 
varying markedly depending on the concentration prepared in the syringe. Insulin 
concentration could not be detected in the solution outside the membrane at 2 µg/ml.  
 
A.3 Conclusion 
The mean insulin recovery was 0.5 %, however, high variability in the insulin 
recovery was found at different insulin concentrations. Insulin adsorption to the plastic 
surface of the microdialysis system appears to be an important factor. Concentration in the 
fluid surrounding the microdialysis probe at 2 ug/ml, was probably decreased due to plastic 
binding. Further work is needed to confirm a concentration-dependent effect on insulin 
recovery via tissue microdialysis.  
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Table AP-1: Optimized mass spectrometry parameters for recombinant human insulin 
(Actrapid) determination on microdialysis dialysate samples using a Shimadzu LCMS-8030 
triple quadruple mass spectrometer.  
Parameter Value 
Nebulizing gas flow 2 l/min 
Heating gas flow 10 l/min 
Interface temperature 300˚ C 
DL temperature 250 ˚ C 
HeatBlock temperature 400 ˚ C 
Drying gas flow 10 l/min 
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Table AP-2: Concentrations of recombinant human insulin (Actrapid) (µg/ml), determined 
using UPLC-MS in samples from the prepared syringe, dialysates and solution outside of the 
microdialysis probe after 4 h of perfusing at 1µl/min an in vitro microdialysis system. 
Prepared 
concentration 
(ug/ml) 
Prepared syringe 
(mean ±SD) 
Dialysate  
(mean ±SD) 
Solution outside of 
the membrane 
(mean ±SD) 
2 2.00 ±0.47 0.09 ±0.09 - 
17 15.90 ±0.07 11.43 ±3.95  0.23 ±0.01 
100 78.68 ±3.48 70.95 ±48.95 0.14 ±0.11 
348 239.94 ±50.79 308.83 ±5.64  0.32 ±0.17 
 
 
 
 
